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ABSTRACT

Proper autonomic regulation of mammalian cardiac function is dependent
upon very complex and precise communication among the intracardiac ganglia
and individual neurons within the ganglia. An array of neuromodulators is found
within the ganglia that direct neuronal activity by modulating the movement of
calcium. The current study determines that opioidergic agonists, which have
been found to contribute to severe cardiac disease states and intracellular
calcium mobilization, are also responsible for changes in the function of the
intracardiac neuron via their effects on store-operated calcium channels (SOCs).
Previous studies suggest that phosphorylation plays a role in SOC
regulation. Using Fura-2 calcium fluorometry, we determined that protein kinase
A (PKA), protein kinase C (PKC), and cyclic adenosine monophosphate (cAMP)
had no effect on store-operated calcium entry in the presence of antagonists,
phorbol 12, 13 dibutyrate (PDBu), forskolin, and 8-Br cAMP, respectively. We
also found pharmacologically that using both electrophysiology and calcium
imaging that µ-opioid agonists, met-enkephalin (ME) and endomorphin (EM)
depress SOC activity in intracardiac neurons.

vii

Arachidonic acid (AA), which

has been found to depress SOC function in rat liver cells and µ-opioid receptor
activation (MOR), blocked both store-operated calcium entry (SOCE) and the
calcium release-activated current (ICRAC) significantly.

Contrastingly, AA

metabolites, prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2), do not
significantly influence SOCE which suggests that the effects of AA may be direct.
The block elicited by EM was partially reversed by pertussis toxin (PTX),
indicative of activation of a PTX-sensitive G-protein following MOR activation.
Similarly, PLA2 inhibitors, OBAA and AACOCF3, decreased the percent block of
SOCE due to opioid agonist-induced inhibition.
Using the perforated-patch method of I-clamp electrophysiology, we
demonstrated that gadolinium, at low micromolar concentrations, reversibly
reduced action potential firing.

Importantly, these results suggest that SOCs

may influence action potential firing in mammalian intracardiac neurons.
Similarly, AA and EM depressed action potential firing. Taken together, these
experiments suggest that a pathway involving EM and AA influences repetitive
firing through SOC inhibition.
The importance of SOCs in the maintenance of action potential firing and
more specifically, the expression and biophysical functionality of the individual
pore-forming subunits (Orai1, 2, and 3) in any neuronal cell type has previously
not been explored.

Quantitative RT-PCR along with I-clamp electrophysiology

revealed that Orai3 was exclusive to repetitively firing neurons. As a result, we

viii

hypothesize that robust Ca2+-dependent fast inactivation, also associated Orai3,
is a factor in the maintenance of repetitive action potential firing.
Using Fura-2 calcium fluorometry and patch-clamp electrophysiology, we
determined pharmacologically that µ-opioid receptor activation precedes an
intracellular cascade that is dependent on a PTX-sensitive G-protein and AA but
independent of prostaglandin and protein kinase activity. Finally, we used RTPCR to determine the Orai subunits expressed in the intracardiac neurons and
their influence on neuronal firing patterns. This study is the first to determine the
role expressed subunits has in the maintenance of the electrical activity of the
neuron.

ix

CHAPTER 1

BACKGROUND AND SIGNIFICANCE

Mammalian Intracardiac Ganglia
The mammalian intracardiac ganglia are composed of clusters of efferent
and afferent neurons that serve as the final common pathway for autonomic
control of cardiac function.

Mediating all parasympathetic input to the heart,

these ganglia receive input from the dorsal motor nucleus (DMN) and nucleus
ambiguus (NA) via ipsilateral fibers of the right and left vagal nerves (cranial
nerve X) (Standish, Enquist et al. 1994). Located superficially on the epicardium
within adipose tissue and embedded within the septum between the two atria, the
epicardial and intraseptal ganglion, control the sinoatrial (SA) and atrioventricular
(AV) nodes, the cardiac myocytes, and the coronary vasculature (Figure 1.1)
(Cuevas 1995) (Ardell and Randall 1986; Randall, Milosavljevic et al. 1986).
Each disparate cluster within the cardiac plexus receives input from
separate regions of the CNS for specialized coordination of cardiac function. For
instance, the SA ganglion, situated at the junction of the right pulmonary vein and
left atrial junction, receives input from the NA resulting in a negative chronotropic
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effect (Gatti, Johnson et al. 1995; Massari, Johnson et al. 1994; Massari,
Johnson et al. 1995). Conversely, the AV ganglion, located at the junction of the
left atrium and inferior vena cava, receives input from both the DMN and NA to
elicit a negative dromotropic effect (Standish, Enquist et al. 1995; Gatti, Johnson
et al. 1995; Massari, Johnson et al.1994; Massari, Johnson et al. 1995).
The ganglia seem to be interconnected within the plexus by a network of
nerve fibers, permitting interganglionic communication (Pardini, Patel et al.
1987). The distribution and quantity of ganglia are different among mammalian
species. For example, there are four ganglionic clusters in the atria and three in
the ventricles of the dog whereas there are four ganglionic cluster groups totaling
4000 neurons in the atria of the rat heart (Fig 1.2) (Armour and Hopkins 1990; Xu
and Adams 1992).
The intrinsic cardiac nerve plexus is by no means a simple relay system
like some other autonomic efferent pathways (Gray, Johnson et al. 2004).
Emerging studies conclude that this circuit is a part of a ranked series of
intrathoracic

nested

feedback

loops

including

interneurons,

afferents,

parasympathetic and sympathetic postganglionic efferent neurons, enabling rapid
and

precise orchestration of cardiac outputs (Ardell, Randall et al. 1988).

Furthermore, the complex morphology of the intracardiac ganglia, representative
of the organ level of the hierarchy of the cardiac nervous system, strongly
suggests that it acts as a major local integration center.

This neurocircuitry

receives mechanical and chemical information from atrial and ventricular origins,
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thus maintaining interganglionic neuronal communication that is also capable of
regulation of reflex short-loop and extracardiac sensory feedback (Fig 1.3)
(Cuevas 1995).
These various pathways function concomitantly to provide beat-to-beat
regulation of the heart. However the intracardiac ganglia are responsible for
integrating the information from these feedback loops spatially and temporally for
precise and accurate output (Armour 1999).

Input from the CNS is not

mandatory for the activity of this plexus. Following chronic decentralization of the
heart, neural communication returns and management of activities such as
contractility, especially, are resumed (Ardell, Butler et al. 1991). The anatomical
structure of the rat intracardiac plexus is similar to that of the human. Therefore,
the rat is an accurate model for the experiments outlined in this dissertation. The
guinea pig cardiac plexus has smaller clusters consisting of about 20 cells
whereas the human and rat have clusters of about 200 cells. These neurons are
more densely populated in the septum in comparison to the atrial walls.
Specifically, more ganglionic neurons are situated near the SA node in the left
atrium than in the right (Leger, Croll et al. 1999).

The rat has four distinct

regions: between the superior vena cava and aorta, within the superior interatrial
septum,

posterior to the left atrium and the posterior to the inferior interatrial

septum and right atrium (Pardini, Patel et al. 1987).
Functionally, there are three types of neurons in the intracardiac ganglia:
principal parasympathetic efferent postganglionic neurons (P), interneurons (IN)
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that

provide

intraganglionic

and

interganglionic

communication,

and

catacholaminergic small, intensely fluorescent cells (SIF) (Xi, Randall et al.
1991).

Principal neurons receive inputs from the CNS, afferent neurons,

sympathetic nerve fibers, INs, and SIFs and synapse on SA and AV nodes, the
myocardium, and the coronary arteries.

Receiving inputs from the CNS and

sympathetic efferents, IN synapse on the P and SIF, which release
catecholamines on P (Seabrook, Fieber et al. 1990).

In addition, there are

afferent neurons that extend from the ganglia to the central nervous system.
Furthermore,

in

addition

to

functionality,

these

neurons

are

morphologically distinct as well. Parasympathetic neurons are usually multipolar
with elongated processes, whereas interneurons are either monopolar or
pseudopolar in appearance (Edwards, Hirst et al. 1995). These cells may also
be categorized by soma diameter as well, with IN being the larger and SIF
having the smallest diameter (Allen and Burnstock 1987; Seabrook, Fieber et al.
1990).
Every cell has a distinct electrical discharge characteristic in addition to
distinct morphological and functional characteristics. In the pig, three distinct
firing patterns have been confirmed: I (phasic), II (accommodating), and III (tonic)
(Smith 1999). In the canine, action potential trains have been described as S, R,
and N, corresponding to phasic firing, tonic firing, and neurons void of firing
activity, respectively (Xi, Thomas et al. 1991; Xi, Randall et al. 1994).
Applicable to the current study, rat cardiac neurons possess three main
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ganglionic neuronal types, Ib, Im, and II. However, there is some heterogeneity
associated with these three types. Ib elicits adapting firing patters, Im exhibits
tonic firing and Type II is capable of both phasic and tonic firing (Selyanko 1992).
The intracardiac plexus has a complex neurohumoral component in
addition to its complex neural network. Indicative of acetylcholine (ACh)
dominance

as

a

neurotransmitter,

choline

acetyl

transferase

(ChAT)

immunoreactivity is present in all postganglionic cells of the guinea pig intrinsic
cardiac ganglia (Mawe, Talmage et al. 1996).

A wide variety of

neurotransmitters and neuropeptides are present in the intrinsic and extrinsic
fibers found within the ganglia and ultimately affect neurons and target tissue.
Neurotransmitters

such

as

ACh,

norepinephrine,

and

dopamine

and

neuropeptides such as pituitary adenylate cyclase-activating peptide (PACAP),
vasoactive intestinal polypeptide (VIP), substance

P, calcitonin gene-related

peptide (CGRP), calbindin, and neuropeptide Y found within the ganglia govern
the electrical properties of the neurons and in turn, the downstream organs are
influenced (Gordon, Polak et al. 1993). There also seems to be subpopulations
of cells within the ganglion displaying common functionality based on
immunoreactivity implicating similar neurochemistries within a subpopulation.
For instance, three distinct neurochemical profiles have been identified within the
guinea

pig

intracardiac

ganglion:

ChAT/NPY,

ChAT/NPY/NOS (Richardson, Grkovic et al. 2003).
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ChAT/NPY/calbindin

and

The study presented here is partially based on the presence of
enkephalin-like activity in the rat heart and the hypothesis that it alters
parasympathetic control over the effector tissues (Hughes, Kosterlitz et al. 1977;
Richardson, Grkovic et al. 2003).

Autonomic Dysfunction and Heart Disease
It is well established that in cardiovascular disease states parasympathetic
drive is compromised. For example, in early stages of heart failure (HF), changes
in vagal discharge can be detected, but the exact mechanism by which this
occurs has not been fully described (Kinugawa and Dibner-Dunlap 1995). Under
normal conditions, the parasympathetic and sympathetic nervous systems
interact by accentuated antagonism in which parasympathetic activation induces
sympathetic depression.

In healthy human subjects, echocardiogram R-R

intervals are augmented in response to subnormal doses of atropine. However,
in the case of HF patients, the effect of atropine on R-R intervals are significantly
reduced a phenomenon indicative of attenuated parasympathetic control.
Epidemiological studies indicate that decreased parasympathetic tone
leads to an increased resting heart rate and a poorer prognosis in heart failure
patients (Fox, Borer et al. 2007).

A reduction in parasympathetic tone, coupled

with an increase in sympathetic tone, leads to an increase risk for ventricular
tachycardia, fibrillation, and ultimately sudden cardiac death (Osaka, Saitoh et al.
1996).

It is commonly preceded by a decrease in heart rate variability, i.e.
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deviations in R-R intervals in sinus rhythm, followed by an electrocardiograph ST
segment shift (Pozzati, Pancaldi et al. 1996).
Relevant to the current study, the attenuation of parasympathetic control
is due to a defect in communication within the intracardiac ganglia (Bibevski and
Dunlap 1999).

Studies indicate that during heart failure, the intrinsic cardiac

nervous system initially maintains its ability to regulate mechano- and chemosensitive inputs, extracardiac efferent neurons, as well as local circuit intrinsic
cardiac neurons. Following disease progression, however, there is restructuring
of the circuitry of the ganglia that blunts its modulatory functions (Arora, Cardinal
et al. 2003).

It has been shown that following myocardial ischemia, the activity

of the intrinsic cardiac neurons is also depressed (Huang, Ardell et al. 1993).
Furthermore, compromised parasympathetic control is frequently associated with
arrhythmias occurring after a myocardial infarction (Kleiger, Stein et al. 2005).
Interestingly, there is evidence that the consequences of direct stimulation of the
fat pads of the epicardium are a reduction in heart rate and sudden cardiac death
in the canine (Wallick and Martin 1990).
In situ, acute myocardial ischemia results in the progression of decreased
soma and dendritic function elicited by the accumulation of reactive oxygen
species (ROS) and purinergic receptor agonists. Originating from surrounding
ischemic myocardial tissue, these factors are then secreted into pericardial fluid
(Huang, Sylven et al. 1993; Huang, Sylven et al. 1995; Thompson, Horackova et
al. 1998). There is also evidence that ganglionic transmission is enhanced in
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response to histamine ligand binding to the H1 receptor of neuronal cells
resulting in the activation of surrounding mast cells (Powers, Peterson et al.
2001). Particularly relevant to this study, cardiac vagal afferents are enhanced
by prostaglandin and ROS-induced sensitization to bradykinin during the immune
response in HF (Schultz 2001). Studies show that VIP regulates vasodilation by
binding to the VPAC receptor on intracardiac neurons and enhancing
neuroexcitability through intracellular calcium elevations (DeHaven and Cuevas
2004). As a result of this altered parasympathetic regulation and subsequent
effects, the myocardium becomes oxygen deprived, contributing to the
progression of the disease state (Huang, Shirahase et al. 1993).

These

examples demonstrate the contribution neurochemistry plays in the pathology of
HF.
The significance of this particular study lies in the paucity of information
that exists about intrinsic cardiac nervous system, its modes of modulation, and
contribution to proper cardiac function.

This study contributes to the

determination of molecular mechanisms by which intracardiac neuronal activity is
modulated by neuromodulators present within the ganglia. Information derived
from studies as the current is key in establishing improved understanding of the
parasympathetic division of the autonomic nervous system and the methods by
which it can be pharmacologically modified (Gheorghiade, van Veldhuisen et al.
2006).
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Calcium Regulation and Excitability of Intracardiac Neurons
Calcium regulation plays an important role in many cell types, particularly
neuronal cell types because of its capacity to regulate gene expression, Ca2+
dependent ion channels, neurotransmitter release, synaptic plasticity, and
excitability. However, mechanisms of intracellular calcium regulation remain to
be

fully

elucidated

in

intracardiac

neurons.

Neurotransmitters

neuromodulators such as acetylcholine (Adams 2004),

and

histamine (Hardwick,

Kotarski et al. 2006), ATP (Liu, Katnik et al. 2000), PACAP, and VIP (DeHaven
and Cuevas 2004) have been shown to modify the activity of these cells by
orchestrating transmembrane and intracellular movement of calcium within these
cells. In addition to plasma membrane fluxes, rat intrinsic neurons display two
intracellular Ca2+ stores, IP3-sensitive stores and caffeine/ryanodine-sensitive
stores (Smith and Adams 1999; Beker, Weber et al. 2003).
Demonstrated by our group, PACAP was able to induce multiple action
potential firing via a calcium-dependent mechanism that required calcium release
from ryanodine-sensitive stores (DeHaven and Cuevas 2004). PACAP and VIP
evoke both a transient as well as sustained phases of cytosolic calcium entry
following VPAC receptor activation.

The transient phase is calcium release

from ryanodine-sensitive stores and the sustained phase is calcium entry through
store-operated calcium channels (SOCs) in neonatal rat intracardiac neurons.
VPAC receptor-dependent membrane depolarizations were observed in the
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presence of both VIP and PACAP. In contrast, studies in guinea pig intracardiac
neurons indicate that neither VIP of PACAP induces the transient phase of
intracellular calcium increases. Furthermore, it is the sustained phase not storerelease that is responsible for any changes in excitability elicited by PACAP
(Tompkins, Hardwick et al. 2006). Taken together, these results are indicative of
differential and specific cellular physiological responses following neuropeptide
ligand binding, justifying the necessity of extensive exploration of intracellular
signaling mechanisms within each species. To date, most of the information that
exists regarding calcium homeostasis involves voltage-gated calcium channels
as the cardinal supplier of calcium to these cells in the maintenance of
excitability. Furthermore, modulation of these channels leads to neurochemical
changes in the guinea pig parasympathetic cardiac ganglia.

For instance, a

decrease in somatostatin gene expression has been attributed to PACAPdependent Ca2+ influx through L-type channels. This finding serves as evidence
of the importance of Ca2+ as it relates to its influences on the neurochemical
composition as well as the electrical activity of the ganglia (Braas, Rossignol et
al. 2004).
Muscarinic as well as nicotinic synergistic receptor activation leads to
calcium release from IP3 and ryanodine sensitive stores in rat autonomic
neurons.

Cholinergic receptor activation is capable of converting excitability

through membrane depolarizations and Ca2+-dependent K+ channels (KCa2+)
(Beker, Weber et al. 2003).

In addition to Ca2+-induced membrane
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depolarization, Ca2+-dependent ion channels contribute to the membrane
properties of these cells. Particularly, KCa2+ channels have been identified and
their

function

and

biophysical

properties

have

been

described

using

electrophysiology (Xu and Adams 1992; Xi-Moy and Dun 1995; Franciolini, Hogg
et al. 2001).
Even though at least three types of depolarization-activated calcium
channels have been identified in intracardiac neurons, action potential firing
occurs quite independently of voltage-gated calcium channel activity (Franciolini,
Hogg et al. 2001). Therefore, there must be a depolarization-independent
component to calcium influx in intracardiac neurons because bath applied,
voltage-gated calcium channel blocker, Cd2+ is unsuccessful in significantly
reducing action potential or after-hyperpolarization (AHP). It is therefore possible
that this component is store-operated (Franciolini, Hogg et al. 2001).

Store-Operated Calcium Channels
Acutely dissociated adult rat intracardiac neurons express four different
subtypes of HVA (high voltage –activated) Ca2+ channels with total contribution
to the total voltage current being in the order of N (63%) > Q (19%) > L (11%) >R
(7%) (Jeong and Wurster 1997).

Franciolini et al. report that selective block of

the V-gated calcium channel has no significant effect on the action potential or
duration of the AHP within intracardiac neurons (2001). The defining
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characteristic of SOCs is their ability to activate in response to the depletion of
calcium from the endoplasmic reticulum. Calcium influx through these channels
embedded within the plasma membrane then replenishes endoplasmic reticulum
(ER) calcium.

Primarily, the ER acts as an intracellular sink for Ca2+, and Ca2+

itself is essential for the proper folding of proteins. It also plays a role in various
processes, such as vesicular trafficking and cholesterol metabolism, and is a
ubiquitous second messenger. When the Ca2+ concentration within the lumen of
the ER falls too low, ER stress occurs and may result in apoptosis (Ferri and
Kroemer 2001). SOCs are capable of refilling the intracellular stores, preserving
protein production, folding, and trafficking (Parekh and Putney 2005).
Capacitative calcium entry (CCE) or store operated calcium entry (SOCE) in
response to intracellular store depletion is important for cell survival and function
of both excitable and non-excitable cell types (Xue, Zhao et al. 2000; Weigl, Zidar
et al. 2003).
To date, the best characterized SOC channel is the channel mediating
calcium release activating current (ICRAC). Analogous to SOCE, ICRAC is evoked
following passive calcium store depletion and inwardly-rectifying given its currentvoltage relationship.

After completing a 1-2s voltage ramp from -100mV to

+100mV and returning to a depolarized potential (0 mV), the driving force for
Ca2+ ions is greatly reduced (Penner, Matthews et al. 1988; Lewis and Cahalan
1989; Bird, DeHaven et al. 2008).

Under physiological conditions the CRAC

channel has significantly high conductance for Ca2+ over monovalent ion species
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indicated by its large amplitude at negative potentials and near zero at positive
amplitudes (>60 mV). However, ICRAC becomes highly selective for Na+ ions in
the absence of Ca2+, potentiating the current (Parekh and Putney 2005; Bird,
DeHaven et al. 2008). Furthermore, the CRAC channel has an allosteric binding
site for Ca2+ ions therefore at nanomolar concentrations the ICRAC is inhibited.
The pore-forming subunit of the SOC channel, Orai1 or CRACM1, was
first identified as non-functional in immune cells of severe combined immune
deficiency (SCID) patients (Feske, Gwack et al. 2006). Two other Orai1
homologs, Orai2 and 3, exist with efficacies in the order of Orai1>Orai2> Orai3,
all capable of regulating and constituting SOCs. The functional properties of
these channel subunits differ from one to another. For instance, Orai1 exhibits
robust fast Ca2+-dependent inactivation whereas Orai2 & 3 do not display fast
Ca2+-dependent inactivation in stably transfected HEK293 cells (Table 1)(Lis,
Peinelt et al. 2007).
Their Orai1-containing channels (Orai1-SOC) are activated in response
to a signal generated by the ER calcium sensor STIM1 (Roos, DiGregorio et al.
2005; Spassova, Soboloff et al. 2006).

Stim possesses an ER luminal helix-

turn-helix Ca2+-sensing EF-hand, “E” and “F” representing the two helixes of the
Ca2+- binding portion of the protein. When ER concentrations fall below 300 µM,
Stim1 oligomerizes and translocates near Orai1 embedded the plasma
membrane to initiate transmembrane entry of extracellular Ca2+ (Liou, Kim et al.
2005; Wu, Buchanan et al. 2006).

Stim2 however inhibits SOCE only after
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coexpression with Stim1 which is indicative the formation of heteromeric puncta
formation (Soboloff, Spassova et al. 2006).
Intracardiac neurons, specifically, display a biphasic Ca2+ response to
PACAP and VIP application that is indicative of store release and subsequent
reentry. More specifically, using the ratiometric calcium imaging along with the
add back protocol, we have shown that SOC antagonists such as SKF-96365
and 2- aminoethoxydiphenyl borate (2-APB) and most importantly, Gd2+, are all
capable of reducing [Ca2+]i during bath application of Ca2+ following passive
store

depletion

caused

by

thapsigargin.

Subsequent

whole

cell

electrophysiological studies indicate that the presence of the ICRAC using precisely
controlled conditions specific for this relatively elusive current. After evoking the
current, application of 5 µM Gd2+ was able to block this current appreciably.
Molecular studies using RT-PCR also indicate the expression of Orai1 mRNA
transcripts in neonatal rat intracardiac neurons. However Orai2 and 3
expressions have not been confirmed prior to the current study.
The one conundrum that investigators are confronted with in the study of
SOCs is that there is not currently an exclusive SOC antagonist. One antagonist,
gadolinium, blocks receptor-operated calcium channels (ROCCs) and SOCs.
However the differentiation lies within the differences in inhibitory concentrations.
Store-operated

calcium

entry,

specifically,

is

depressed

by

Gd3+

at

concentrations under 10 µM. Other inhibitors such as 2-APB and SKF-96935
inhibit voltage-dependent Ca2+ channels at similar concentrations. As a result
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Gd2+, at micromolar concentrations, is accepted as the most selective SOC
antagonist to date (Franzius, Hoth et al. 1994).
From one Orai subunit to the next, the pharmacology of each is distinct.
For instance, SOC antagonist, 2-APB significantly blocks Orai1 directly and
prevents Stim1 puncta formation. In the case of Orai2, 2-APB elicits inhibition to
a lesser degree than Orai1 whereas, it potentiates Orai3 in HEK 293 cells
transiently transfected with the Orai and Stim (Table 1). Furthermore, we must
conclude that 2-APB acts through very intricate mechanisms in the regulation of
SOC channels in the exploration of this relatively novel ion channel (DeHaven,
Smyth et al. 2008).

A Stim1 homolog, Stim2, exhibits dual modes of SOC

regulation by store and calmodulin (CaM) dependence.

CaM is proposed to

have a dual inhibitory role first by its interaction with the Orai-Stim complex and
inhibition of the IP3 receptor (Parvez, Beck et al. 2008).
While these channels have been studied to some extent in non-excitable
cells, little is known about the functional properties and cellular role of Orai1-SOC
in neurons. In dorsal root ganglion neurons, a Ca2+ current has been evoked
following ER store depletion and blocked by 2 µM Ni2+ at hyperpolarized
potentials (Usachev and Thayer 1999). For the first time in a neuronal subtype,
our group has successfully confirmed molecularly and pharmacologically the
presence of functional SOCs. Therefore we propose that SOCs may be as
integral as V-gated calcium channels in the regulation of Ca2+-dependent
potassium channels thereby influencing cell-to-cell communication within the
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intracardiac ganglia. Additionally, the current study is based on the premise that
Orai- SOCs are functionally expressed in neonatal rat intracardiac neurons and
µ-opioid receptors purported to be expressed in this neuronal cell type regulate
SOC channel activity.

µ-opioid Receptor Activation
Enkephalins and dynorphins are two classes of opioid agonists that are
endogenous to the heart and are potent regulators of cardiac function.
Enkephalins have negative effects on heart rate, contractility, and electrical
conduction at synapses of vagal preganglionic neurons as well as other targets
within the central and peripheral nervous system (Blinder, Johnson et al. 2005;
Caffrey, Gaugl et al. 1985). Under normal conditions in the adult mammalian
heart, the mRNA encoding for the precursors proteins proenkephalins and
prodynorphins are readily detected, but the processed protein end products are
sparse (Springhorn and Claycomb 1992; Boluyt, Younes et al. 1993; Caffrey,
Boluyt et al. 1994; Barlow, Deo et al. 2006). However, endogenous as well as
circulating opioids are elevated in individuals with genetic hypertension,
myocardial infarction, and cardiomyopathy and in cardiac transplant patients
(Dumont, Ouellette et al. 1991; Ationu, Sorensen et al. 1993; Barlow, Deo et al.
2006). Circulating opioids, specifically, are elevated in patients with congestive
heart failure, leading to the exacerbation of the disease state by reducing cardiac
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output (Liang, Imai et al. 1987; Fontana, Bernardi et al. 1993; Barlow, Deo et al.
2006).
Opioid antagonist U50,488H promotes bradycardia, arrhythmias, and
hypotension associated with myocardial ischemia (Lee, Chen et al. 1992). In a
clinical study, met-enkephalin (ME) administered to a group of patients with
neurocirculartory dystonia, myocardial ischemia and arterial hypertension nearly
doubled sinus node recovery time and shortened the cardiac cycle (Osadchii,
Abushkevich et al. 2001). Taken together these studies indicated that as
parasympathetic mediators regulating heart rate primarily, intracardiac neurons
could possibly be affected by endorphin activity.
Enkephalins injected centrally in the NA and locally in vagal preganglionic
nerve fibers have cardioinhibitory effects. (Laubie, Schmitt et al. 1979; Wu and
Martin 1983; Blinder, Johnson et al. 2005).

Independently, this evidence

overwhelmingly suggests that similar effects will be seen in postganglionic
intracardiac neurons. On the other hand, opioids are capable of inhibiting
catecholamine release and simultaneously being produced in dissociated cardiac
myocytes by adrenergic second messengers. Autonomic cross talk is mediated
thereby limiting end-organ responses to nerve stimulation through this opioidinduced feedforward effect (Barron and Hexum 1986; Wong and Lee 1987;
Wong, Lee et al. 1990).

The exact mechanisms by which opioids exert their

effects at the tissue and cellular level to produce these cardiovascular effects are
poorly understood.
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An additional method of opioid-induced modulation of the nervous system
is via ion channels, specifically, calcium channels.

Previous studies have

identified opioid receptor agonists as modulators of ion channels particularly,
VGCCs.

In parasympathetic neurons of the NA, µ-opioid receptor (MOR)

activation has been shown to inhibit voltage-gated calcium channels and the rat
superior cervical ganglion, respectively (Liu and Rittenhouse 2003). Based upon
these findings, opioids may be capable of regulating the activity of the ganglia by
modulating calcium channels, specifically.
Pharmacologically, opioidergic agonists function, partly, in the attenuation
of pain by reducing pre-synaptic neurotransmitter release, which is dependent
upon Ca2+ currents (Jessell 1977; Wilding, Womack et al. 1995).

In adult rat

ventricular myocytes, leu-enkephalin dampens L-type calcium channel activity
leading to a reduction in the ionotropic response (Xiao, Spurgeon et al. 1993).
The greatest contributor to the voltage-gated calcium current (ICaV) in adult rat
intracardiac neurons, N-type calcium current is significantly reduced by µ-opioid
specific agonist, ME, in a reduction of the amplitude of the single action potential
waveform (Adams and Trequattrini 1998). Also, leu-enkephalin reduces
contraction amplitudes in ventricular myocytes through the blockade of L-type
calcium channels (Xiao, Spurgeon et al. 1993).
Intracellular pathways are initiated which activate and produce second
messengers that the direct consequences on ion channel activity.

Through G-

protein recruitment, the PLC-IP3/DAG and AC-cAMP pathways are initiated and
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orchestrate intracellular calcium store release (Johnson, Wang et al. 1994).
Relevant to the current study, the Adams group has proposed that opioid ligands
induce IP3-mediated calcium mobilization (Smith and Adams 1999) as well as
block VGCCs in rat intracardiac ganglion neurons (Adams and Trequattrini
1998).

Taken together, it is possible that these agonists may activate an

intracellular signaling cascade targeting SOC channels.
Given that G-protein recruitment precedes voltage-gated calcium current
inhibition in NG-108 cells transfected with cloned µ-opioid receptors, this study
aims to explore the role of G-proteins in an intracellular second messenger
system resulting in SOC depression in cardiac neurons (Higashida, Hoshi et al.
1998).

Furthermore, MOR activates phospholipase A2 (PLA2), the enzyme

responsible for production of the intracellular second messenger AA in pyramidal
neurons (Faber and Sah 2004). This finding is relevant to the present study
because AA has been shown to be the signaling molecule responsible for SOC
inhibition in rat liver cells. This study is novel because it attempts to establish a
link among G-protein, PLA2, AA activation and SOC activity reduction in an
excitable cell type.
Under normal conditions in mammalian cardiac tissue, unesterified
arachidonic acid (AA) concentration is low however following ischemia and
reperfusion, AA is produced, having adverse effects on cardiac function (Van der
Vusse, Reneman et al. 1997).

It is possible that these negative consequences

are due the dampening of sarcoplasm Ca2+, voltage-gated calcium channels
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(VGCCs), K+, and Na+ channel function (Huang, Xian et al. 1992; Honore,
Barhanin et al. 1994; Kang and Leaf 1996). In non-excitable cells such as rat
liver cells, AA is a highly effective inhibitor of SOC function at estimated
physiological concentrations (Rychkov, Litjens et al. 2005). However, the effects
of AA on SOC channels in neurons remain a mystery.
This study was executed to explore the effect of MOR ligands, AA, and the
possibility of the two participating in a common inhibitory pathway for SOC
channel activity in the cardiac neuron.

It is our hypothesis that opioidergic

receptor activation results in the PLA2-mediated production of AA only following
G-protein recruitment in rat intracardiac neurons.
potential

discharge

and

intraganglionic

and

Consequently, the action
interganglionic

compromised, resulting in altered autonomic regulation of the heart.
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function

is

Figure 1.1 Schematic diagram of intracardiac ganglia and effector tissues.
Note the interganglionic connections. AV, atrioventricular node; SA, sinoatrial
node (Cuevas 1995)
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Figure 1.2 (A) Representative sketch of the organization of intracardiac neurons within
the heart. Each dot is an individual ganglion. Superior view of LA, left atrium and RA,
right atrium. Scale bar, 1 µm
m PV, pulmonary veins; SVC, superior vena cava ( B)
Intracardiac neurons in vivo under Hoffman modulation contrast optics, Scale bar, 40 µm
(C) Phase contrast photomicrograph of neurons enzymatically dissociated from rat
cardiac ganglia and entered into culture for approximately 48 hours. Scale bar, 100
10 µm.
(Xu and Adams 1992)
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Figure 1.3 Schematic diagram of the organization of intrathoracic cardiac plexus.
R, Receptor (Cuevas 1995)
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Table 1. Functional, Kinetic, and Pharmacological Properties of Orai
Channels; adapted from (Lis, Peinelt et al. 2007)
Orai1

Orai2

Orai3

Store-Operated

Yes

Yes

Yes

Activation time
(t 1/2)

35 + 7 s

21 + 3 s

63 + 7 s

Ca2+-dependent
inactivation (fast)

Moderate

Moderate

Strong

Ca2+-dependent
inactivation
(slow)

Strong

None

None

Ca2+-dependent
reactivation
Selectivity

Yes

No

No

Ca2+>> Na+, Ba2+

Ca2+>>Na+, Ba2+

Ca2+>> Na+, Ba2+

Moderate

Moderate

Strong

Block

Reduction

Potentiation

Monovalent
Permeations in
DVF solutions
2-APB at 50 µM
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CHAPTER 2

RECRUITMENT OF INTRACELLULAR KINASES HAS NO APPRECIABLE
INFLUENCE ON STORE-OPERATED CALCIUM ENTRY IN INTRINSIC
CARDIAC NEURONS

INTRODUCTION

The mammalian intracardiac ganglia mediate parasympthetic input to the
heart through very complex neural interations. However the cellular mechanisms
by which this neural network processes vagal input remain to be fully elucidated.
It has been established that these ganglia serve as the final common pathway for
the integration of a variety of exogenous inputs ultimately orchestrating end
organ function. Communication within the ganglia and target modualtion is highly
dependent upon the neurochemistry of the ganglia. Similarly, the neurochemical
component of this plexus is also very complex and the exact mechanism by
which these neuromodulators control the cardiac ganglia is poorly understood.
In order to begin to fully assess the the mechanisms by which these
neuromodulators exert their effects, we must first explore the effects on the
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single neuron. Neuronal excitability is determined by the membrane properties
of the cell, biochemical interactions between intracellular and extracellular
molecules, and membrane-bound ion channels.

Specifically, neuropeptide-

induced calicum channel modulation has been implicated in the function of
intracardiac neurons. For example, vasoactive intestinal poplypeptide (VIP) and
pituitary adenylate cyclase-activating polypeptide (PACAP) increase excitability
of intracardiac neurons by calcium-induced membrane depolarizations (Smith
and Adams 1999; Liu, Cuevas et al. 2000; Liu, Katnik et al. 2000; Beker, Weber
et al. 2003; DeHaven and Cuevas 2004).

VIP exerts its effects through the

mobilization of calcium through vasointestinal pituitary adenylate cyclase
receptor (VPAC)

activation.

Following intracellular store release, there is a

sustained phase of the calcium response that is blocked by store-operated
calcium channel (SOC) antagonist 2-aminoethoxydiphenyl borate (2-APB).
VPAC receptor activation initiates an intracellular signalling cascade that leads to
an inositol 1, 3, 4-triphosphate (IP3) -induced store release.

Furthermore,

previous studies show that VIP-mediated regulation of voltage-gated calicum
channels (VGCCs) is cyclic adenosine monophosphate (cAMP)/ protein kinase A
(PKA)-dependent. However, the role kinases play in SOC regulation is unclear.
Even though VGCCs have traditionally been thought to be the primary
excellular calcium source and modualtors of excitability in neuronal cell types,
emerging evidence shows that SOCs are expressed and may play role in the
function of intracardiac neurons.

SOCs are capable of being regulated by the
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receptor-operated intracellular second messenger systems.

Confirmed to be

expressed in intracardiac neurons, muscarinic (M1 and M3), P2Y2 , and PAC1,
recruit protein kinase C (PKC), which influences store-operated calcium entry
(SOCE) (Strassheim and Williams 2000; Zhou, Yada et al. 2001; Dejda, JozwiakBebenista et al. 2006; Watanabe, Ohba et al. 2006). Pituitary adenylate cyclase
(PAC1) and VPAC2 receptors couple to adenylate cyclase (AC), which activates
kinases. As a consequence, these kinases modulate SOCs directly. (Chatterjee,
Sharma et al. 1996; Lutz, Shen et al. 1999).
Protein amino acid sequences may be evaluated

and compared to

kinase sequences offering a method for determining possible kinase subtypes
that are coupled to ion channel subunits.

Using Netphosk1.0,

we have

identified putative PKA and PKC binding sites on the first subtype of the poreforming subunit of the store-operated calcium channel, Orai1. Preliminary to
determining the functional coupling of kinases to the Orai-SOC channel, this
finding is also indicative of a possible kinase regulatory component of

the

sustained phase of Ca2+ increase elicited by PACAP.
There is some controversy that exists in the literature regarding the
influence that kinases have on SOCE. For instance, PKC has been found to
have negative effects on

capacitative calcium entry (CCE) in Drosophila

photoreceptors and human neutrophils (Hardie, Peretz et al. 1993; Montero,
Garcia-Sancho et al. 1994). Studies elucidating the link between SOCE and
endothelial cell permeability show that myosin light-chain kinase (MLCK) alone
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and not PKA or PKC influences this process (Norwood, Moore et al. 2000). In
pulmonary smooth muscle

cells, PKA blocks while PKC promotes

store-

operated calcium channel function (Chen, Dai et al.).
It is important to determine the role of these kinases in regulating SOC in
intracardiac neurons because electrophysiological studies done by our group
show that SOC function is intergral in maintaining the electrical activity of the
neuron.

2-APB and Gd3+,

Known SOC antagonists,

at SOC-specific

concentrations, attenuate action potential firing in intracardiac neurons, which
suggests that repetitive firing is SOC-dependent.
The biophysical properties of these neurons are critical to acetyl choline
(ACh) release, which dictates sequential cell-to-cell communication with in the
ganglia.

These interations will ultimately influence the efficiency of the

integration of information received by the CNS and ultimately affect cholinergic
drive to the vasculature, myoctes, and nodal tissue of the heart. This study
ascertains, using fura-2 mediated calcium flurometry, that store-depletion calcium
entry is unaffected by PKA or PKC.
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METHODS

Cell Culture
All animals used in this study were Sprague-Dawley neonatal rats,
sacrificed using rapid decapitation at 2-4 days old. All procedures were done in
accordance with the regulations of the Institutional Animal Care and Use
Committee.

Preparation and culture of neurons were followed as previously

described (Fieber and Adams 1991).

Enzymatically dissociated neurons were

fixed on poly-L-lysine coated coverslips and incubated for 2-5 days in 95% air
and 5% CO2 at 37oC. Following cell culture, isolated neurons were used for
calcium imaging studies.

Ratiometric Calcium Fluorometry Measurements
Fluctuations in intracellular calcium concentrations were measured using
fluorescent imaging techniques.

Fura-2-acetoxymethylester (fura-2-AM) was

used as the indicator to measure [Ca2+]i in the intracardiac neurons. Cells plated
on coverslips were incubated for 1h in physiological saline solution (PSS): 140
mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 7.7 mM glucose and 10 mM
Hepes (pH to 7.2 with NaOH) and 3 µM fura-2-AM plus 0.1% dimethyl sulfoxide
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(DMSO). All solutions were administered focally via a rapid application system
(Cuevas and Berg, 1997).
Methods for calcium imaging experiments were identical to those
previously described (DeHaven and Cuevas 2004). Fluorescence emissions
were captured using a Sensicam digital CCD camera (Cooke Corp., Auburn Hills,
MI) and recorded using Slidebook Version 3 Software (Intelligent Imaging
Innovations, Denver, CO). Changes in [Ca2+]i were calculated using Slidebook 3
software (Intelligent Imaging Innovations, Denver, CO) from the intensity of the
emitted fluorescence following excitation with 340- and 380-nM light, respectively
using the Grynkiewicz equation:

[Ca2+]i = Kd Q(R-Rmin)/(Rmax –R)

(Eq.1)

Where R denotes the fluorescence intensity ratio (F340/F380) as determined as
a result of experiments, Q is the ratio of Fmin to Fmax at 380 nM and Kd is the Ca2+
dissociation constant for fura-2. Calibration of the system was performed using
fura-2 calcium imaging calibration kit (Molecular Probes, Inc., Eugene, OR).
These values were determined as follows: Fmin /Fmax = 224; Rmin = 0.198977;
Rmax= 7.5354.
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Reagents and Statistical Analysis

The following agents were used in this study: Forskolin, PDBu, 8-Br-cAMP
(Sigma), and fura-2-AM (Molecular Probes, Inc., Eugene, OR). Imaging data
files were converted to text format and imported into SigmaPlot 11 and Clampfit
9.2 for analysis. Statistical analysis was performed by SigmaPlot using paired
and unpaired t-tests to determine significance within a group. The differences
between groups are significant if p<0.05.
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RESULTS

PKC activation has no influence on SOCE
To determine whether PKC activation influences SOC activity, fura-2
mediated calcium imaging was used to measure changes in SOCE in the
absence and presence of PKC activation by phorbol 12, 13 dibutyrate (PDBu).
Cells were preincubated overnight in media containing 1 µM PDBu, or in normal
media, and population studies were used to determine the effects of PDBu on
SOCE. The add-back protocol was initiated in fura-2 loaded neurons through the
activation of passive depletion of intracellular Ca2+ stores by thapsigargin (TG) in
a calcium-free PSS solution. Baseline levels of calcium were recorded prior to
the introduction of 2.5 mM calcium PSS to the bath.

Next, the resultant

intracellular calcium increases were measured in neurons that had been exposed
to 1 µM PDBu overnight and allowed to wash for 5 min and in naïve neurons in
order to evaluate significant changes in SOCE. In Figure 2.1A, representative
traces of intracellular calcium concentration as a function of time during Ca2+ add
back from two neurons are shown. The solid line is indicative of the add-back
response in the absence of PDBu and the dashed line, the presence of PDBu.
The intracellular increases in both control and drug treated groups were 146+10
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nM and 150 +11 nM and were not statistically different (Figure 2.1B).

The

results represented here suggest that the PKC activation does not influence the
magnitude of SOCE in rat neonatal intracardiac neurons.

PKA activation does not contribute to the regulation of SOCE
In pulmonary smooth muscle cells, PKA inhibitor H-89 activates SOCE
(Chen, Dai et al.). Similarly, NetPhosk1.0 results indicate that Orai1 has putative
binding sites for PKA.

To determine whether the pore-forming subunit is

influenced by the kinase in neonatal intracardiac neurons, calcium imaging with
the add-back protocol were used to determine the role PKA has in SOC
modulation. The membrane permeable cAMP analog, 8-Br-cAMP, will be used
to mimic the effects of cAMP and activate PKA. Fura-2 loaded cells were pretreated with 4 µM TG to passively deplete the stores. Mean peak calcium levels
were recorded and analyzed before (Control) and after (cAMP) drug
presentation. Representative traces show qualitatively that application of 8-BrcAMP has no effects on SOCE, and thus, PKA is unlikely to be affecting SOC
(Figure 2.2A).

The solid line is indicative of control conditions; while the

dashed line is a representative trace from the same cell following 8-Br-cAMP
application.

The bar graph in Figure 2.2B also shows the mean peak calcium

levels for control (162 +15 nM) and drug-treated groups (151 +16 nM). These
groups were not statistically different. PKA has no considerable influence on
SOCE in neonatal rat intracardiac neurons.
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CCE is unaffected by an AC-cAMP pathway
To confirm the observations made with 8-Br-cAMP, the AC-cAMP
pathway was activated to indirectly activate PKA and determine the consequence
this pathway has on SOCE.

Similar to aforementioned experiments, store-

depleted neurons were exposed to a calcium- PSS solution to induce intracellular
calcium increases. In this set of experiments, forskolin, an adenylate cyclase
activator, was applied to cells to promote the production of cAMP.

Figure 2.3

demonstrates the outcome of experiments in which the intracellular calcium
concentrations were assessed following add back (solid line) of calcium before
and after adenylate cyclase-activator, forskolin (Forsk), application.

The mean

peak calcium levels were determined to be 128 ± 8 nM for control group and 137
± 17 nM.

Statistical analysis shows that these values are not different.

Representative traces of changes in intracellular calcium levels in response to
add back are shown (Figure 2.3B).

These results confirm that the AC-cAMP-

PKA pathway, similar to direct activation of PKC and PKA, have no significant
effects CCE.
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Figure 2.1. PKC activation has no influence on SOCE. A, Representative
traces of ∆[Ca2+]i for two individual neurons using the add back protocol for
control (solid, n=59), a treatment of 1 µM PDBu (dashed, n=42). Line above
trace represents 2.5 mM Ca2+ application. B, Bar graph of values mean (±
SEM) Peak ∆[Ca2+]i for control, drug-treated, and wash groups for the duration
of the add back. There is no significant difference from control group.
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Figure 2.2. PKA activation does not contribute to the regulation of SOCE. A,
Representative traces of ∆[Ca2+]i for two individual neurons using the add back
protocol for control (solid, n=45), a treatment of 100 µM cAMP (dashed, n=27).
Line above trace represents 2.5 mM Ca2+ application. B, Bar graph of values
mean (± SEM) Peak ∆[Ca2+]i for control, drug-treated, and wash groups for the
duration of the add back. There is no significant difference from control group.
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Figure 2.3. CCE is unaffected by an AC-cAMP pathway. A, Representative traces of
∆[Ca2+]i for two individual neurons using the add back protocol for control (solid, n=72),
a treatment of 10 µM Forskolin (dashed, n=23). Line above trace represents 2.5 mM
Ca2+ application. B, Bar graph of values mean (± SEM) Peak ∆[Ca2+]i for control, drugtreated, and wash groups for the duration of the add back. There is no significant
difference from control group.
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DISCUSSION

In this study, we conclude that phosphorylation by PKA and PKC has no
appreciable effect on SOCE

in

intracardiac neurons.

This study is novel

because published information that exists on phosphorylation of SOCs applies to
non-excitable cells.

This study attempts to begin to determine possible modes

of SOC regulation in excitable cells and the contribution SOCE has on neuronal
function.
First, using calcium imaging and PKC activator PDBu, we show that PKC
does not potentiate nor does it block intracellular calcium elevations following
store depletion in intrinsic cardiac neurons. Our findings concur with studies in
other cell types, such as endothelial cells, that cite that PKC has no bearing on
the function of SOCs (Norwood, Moore et al. 2000) .

It is possible that PKC

had an indirect effect on store-depletion versus the channel itself in previous
studies (Berridge 1995). However, in the present investigation, stores were
passsively depleted

prior to experiments, consequently this variable was

eliminated.
NetPhosk analysis output results indicated that there are putative binding
sites for PKC and PKA on the Orai1 subunit. However, NetphosK provides
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predicted results based on the amino acid sequences and mathematics. Further,
binding studies would be apporiate to confirm protein-protein interaction.
Next we used an identical protocol, but with the membrane permeable
cAMP analog, 8-Br-cAMP, to determine if cAMP and/or the downstream kinase,
PKA, can affect SOC activity in these cells. Similarly, no appreciable differences
in SOCE could be detected when 8-Br-cAMP was bath applied during the add
back. Conversely, Zhou et. al. report that an AC-cAMP-PKA intracellular
signalling cascade is initiated following PAC1 receptor binding in neuroepithelia
cells (2001).

These conflicting findings suggest that the effects elicited by

kinases could be dependent upon cell type.
The conclusions drawn from the 8-Br-cAMP experiments were supported
by studies using the AC activator, forskolin.

Forskolin failed to evoke any

changes in SOCE in this sytem. The published data that exists linking cAMP to
SOCE is conflicting. In airway smooth muscle cells, cAMP blocks SOCs (Ay,
Iyanoye et al. 2006). However, there is also evidence that this phenomenon
could be due to upstream effects on the unloading of the stores. For instance,
histamine and ACh hydrolyze IP3 via cAMP, leading to a decrease in intracellular
calcium mobilization, thus causing a decrease in SOC channel modulation
(Raeymaekers, Eggermont et al. 1990). In rat aorta, cAMP is a SOC antagonist;
while in astrocytes cAMP acts as an agonist for SOCE (Wu, Chen et al. 1999).
Taken together, these studies suggest that differences in kinase activity may be
due to differences in cell type. More cell type specific studies would need to be

47

performed to determine these differences in regulation and the factors that
contribute to these differences.
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CHAPTER 3

µ-OPIOID RECEPTOR ACTIVATION BLOCKS SOCE AND THE ICRAC VIA AN
ARACHIDONIC ACID MEDIATED PATHWAY IN RAT INTRACARDIAC
NEURONS

Introduction

Decreased parasympathetic modulation of the diseased mammalian heart
allows sympathetic regulation to predominate, which could lead to ventricular
dysrhythmias and ultimately, sudden cardiac death.

The mammalian

intracardiac ganglia are groups of parasympathetic efferent and afferent neurons
that serve as the final common pathway to autonomic control of local cardiac
function neurons modulating conduction, contractility, and vascular tone (Ardell
2004). Additionally, intrinsic cardiac neurons function locally to provide rapid
sensory feedback and contribute to the maintenance of proper cardiac function
independent of the CNS (Ardell 1994).

Enkephalins and dynorphins are two

classes of opioid agonists that are endogenous to the heart and are potent
regulators of cardiac function. Under normal conditions in the adult mammalian
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heart, the mRNA encoding for the precursor proteins proenkephalins and
prodynorphins are readily detected, but the processed protein end products are
sparse (Springhorn and Claycomb 1992; Boluyt, Younes et al. 1993; Caffrey,
Boluyt et al. 1994; Barlow, Deo et al. 2006). However, endogenous as well as
circulating opioids are elevated in individuals with genetic hypertension and
cardiomyopathy and in cardiac transplant patients (Dumont, Ouellette et al. 1991;
Ationu, Sorensen et al. 1993; Barlow, Deo et al. 2006).

Circulating opioids,

specifically, are elevated in patients with congestive heart failure (Liang, Imai et
al. 1987; Fontana, Bernardi et al. 1993; Barlow, Deo et al. 2006).
Activation of µ-opioid receptors (MOR) in these neurons produce
elevations in [Ca2+]i but results in depression of excitability (Smith and Adams
1999). In contrast, two neuropeptides found within the mammalian intracardiac
ganglion,

pituitary

adenylate

cyclase

activating

peptide

(PACAP)

and

vasointestinal polypeptide (VIP), have been shown to enhance the excitability of
intracardiac neurons via a mechanism dependent on similar elevations of
intracellular calcium concentrations ([Ca2+]i) (DeHaven and Cuevas 2004).
Obviously, these neuromodulators exert their opposing effects on membrane
properties of the neuron via different mechanisms.

While the MOR agonist

depletes intracellular calcium stores, VIP and PACAP elicit a sustained [Ca2+]i
increase, store release, that precedes a transient intracellular calcium response,
influx through channels on the plasma membrane.

This phenomenon is

capacitative calcium entry (CCE) or store-operate calcium entry (SOCE); that is,
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calcium influx regulated by Ca2+ concentrations within the cellular stores. The
transient phase is reduced in the presence of SOC antagonist, 50 µM 2-APB,
which indicates that VIP and PACAP are able to evoke a SOCE response in rat
intracardiac neurons.
The Adams group has proposed that opioid ligands induce IP3-mediated
calcium mobilization as well as blockade of voltage-gated calcium channels
(VGCCs) in rat intracardiac neurons (Adams and Trequattrini 1998; Smith and
Adams 1999). Taken together, it is possible that these agonists may play a role
in the function of SOC channels. Furthermore,

Franciolini et al. report that

selective block of the voltage-gated calcium channel has no significant effect on
the action potential or duration of the after-hyperpolarization (AHP) within
intracardiac neurons

(2001). In support of this study, electrophysiology

experiments indicate that there is more than one functional type of calcium
channel in the intracardiac neuron (Xu and Adams 1992). While VGCCs have
been established as the key regulator of calcium mobilization in the intracardiac
neurons, these results suggest that SOCs may play a significant role in action
potential firing.
SOCs are important because they ensure availability of calcium in
response to depletion of intracellular stores. The most concise description of the
current as related to SOCE is the calcium release-activating calcium current
(ICRAC).

Evoked following passive calcium store depletion, this current was

initially characterized in rat mast cells and human leukemic T cells (Penner,
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Matthews et al. 1988; Lewis and Cahalan 1989).

Under physiological

conditions, the CRAC channels have significantly high preference for Ca2+ over
monovalent ion species however ICRAC becomes highly selective for Na+ ions in
the absence of Ca2+ (Parekh and Putney 2005; DeHaven, Smyth et al. 2008).
Orai-1, one of three pore-forming subunits composing SOCs, has been shown to
be functionally expressed in intracardiac neurons (unpublished data).

It was

recently characterized in immune cells of severe-combined immune deficiency
(SCID) patients that express a mutated Orai-1 protein (Carr, De Costa et al.
1991; Feske, Prakriya et al. 2005).

However, its contribution to the function of

the cardiovascular system is unknown.
It is important to understand consequences of aberrant SOC channel
function on cellular physiology whether by changes in molecular expression or
pharmacologically. Therefore this study is based on the premises that opioid
peptide production is altered in certain cardiac conditions and these changes
could

in

turn

have

detrimental

consequences

on

ganglionic

function,

exacerbating the disease. While the δ-opioid receptor is the predominant class
of opioid receptor in mostly non-neuronal cardiac tissue (Wittert, Hope et al.
1996; Zimlichman, Gefel et al. 1996; Bell, Sack et al. 2000), the MOR is of
particular interest because recent studies in intracardiac neurons suggest that µopioidergic signaling inhibits N-type calcium channels (Adams and Trequattrini
1998). MOR activation also leads to the recruitment of phospholipase A2 (PLA2),
the enzyme responsible for AA production in pyramidal neurons thus altering
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action potential discharge (Faber and Sah 2004).

In non-excitable cells such as

rat liver cells, AA is a highly effective inhibitor of SOC function at estimated
physiological concentrations (Rychkov, Litjens et al. 2005). MOR activation and
AA production have been shown to inhibit voltage-gated calcium channels in
parasympathetic neurons of the nucleus ambiguus (NA) (Irnaten, Aicher et al.
2003) and the rat superior cervical ganglion (Liu and Rittenhouse 2003),
respectively.

However, the effects of AA on SOC channels in neurons and

influences on membrane properties of the neuron remain a mystery. Previous
studies done by our group show that two important excitatory neuromodulators,
VIP and PACAP, act via a PTX-sensitive G-protein in intracardiac neurons (Liu,
Cuevas et al. 2000). Additionally, in pyramidal neurons of the amygdala, it has
been shown that a PTX-sensitive G-protein linked to the MOR receptor causes
the activation of PLA2 when the G-protein subunits dissociate (Faber and Sah
2004). Relevant to the current study, we hypothesize that a G-protein is involved
in the signaling cascade coupling MOR to SOC.

For instance, Jelson et.al

report changes in the action potential waveform following cardiac ganglionic mast
cell degranulation as the result of the inhibition of small-conductance calcium
channels (SKCa2+) by prostaglandins. However it remains unclear whether
prostaglandins inhibit the channel directly or via Ca2+ channels.
We show that MOR ligands and arachidonic acid are involved in a
common inhibitory pathway for SOC channel regulation in cardiac neurons and
could possibly be influential in the neuromodulation of cardiac function. First,
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using ratiometric calcium imaging, we show that SOCE is attenuated by MOR
agonists and AA and linoleic acid (LA) alike. However these effects of MOR
activation are reduced in the presence of the PLA2 antagonist, 4-(4Octadecylalkybenzoylacrylic acid (OBAA), suggesting that AA production follows
receptor activation in a common signaling cascade. AA metabolites, PGE2 and
PGD2, present in the cardiac ganglia have no apparent effects on SOC function,
indicating that they do not function downstream of AA in the depression of SOC
activity.

Finally, using whole-cell patch clamp electrophysiology, the ICRAC is

reduced by AA and endomorphin-1 (EM), concluding that Orai-SOCs are the
specific targets in the MOR-mediated intracellular pathway.

56

METHODS

Cell Culture
All animals used in this study were Sprague-Dawley neonatal rats,
sacrificed using rapid decapitation at 2-4 days old. All procedures were done in
accordance with the regulations of the Institutional Animal Care and Use
Committee.

Preparation and culture of neurons were followed as previously

described (Fieber and Adams 1991). Enzymatically dissociated neurons were
fixed on poly-L-lysine coated coverslips and incubated for 1-5 days in 95% air
and 5% CO2

at 37oC. Following cell culture, isolated neurons were used for

both calcium imaging and electrophysiological studies.

Ratiometric Calcium Fluorometry Measurements
Fluctuations in intracellular calcium concentrations were measured using
florescent imaging techniques.

Fura-2-acetoxymethylester (fura-2-AM), was

used as the indicator to measure [Ca2+]i in the intracardiac neurons. Cells plated
on coverslips were incubated for 1hr. in physiological saline solution (PSS): 140
mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 7.7 glucose and 10 mM
Hepes (pH to 7.2 with NaOH) and 3µM fura-2-AM plus 0.1% dimethyl sulfoxide
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(DMSO). All solutions were administered focally via a rapid application system
(Cuevas and Berg, 1997).
Specifications for calcium imaging experiments are as previously
described (DeHaven and Cuevas 2004). Fluorescence emissions were captured
using a Sensicam digital CCD camera (Cooke Corp., Auburn Hills, MI) and
recorded using Slidebook Version 3 Software (Intelligent Imaging Innovations,
Denver, CO). Changes in [Ca2+]i were calculated using Slidebook 3 software
from the intensity of the emitted fluorescence following excitation with 340- and
380-nM light, respectively using the Grynkiewicz equation:

[Ca2+]i = Kd Q(R-Rmin)/(Rmax –R)

(Eq.1)

where R denotes the fluorescence intensity ratio (F340/F380) as determined as a
result of experiments, Q is the ratio of Fmin to Fmax at 380 nM and Kd is the Ca2+
dissociation constant for fura-2. Calibration of the system was performed using
fura-2 calcium imaging calibration kit (Molecular Probes, Inc., Eugene, OR).
These values were determined as follows: Fmin /Fmax = 224; Rmin = 0.198977;
Rmax= 7.5354.
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Whole-Cell Patch Clamp Electrophysiology
Coverslips containing neurons cultured as described above were
transferred to a recording chamber mounted on a phase contrast microscope and
visualized at 400X. Intracardiac neurons were electrically accessed using whole
cell patch clamp recording techniques as described previously (Cuevas and
Adams 1994). Cells were exposed to normal PSS, PSS nominally calcium free
(NCF), which contained no added CaCl2 or divalent-free PSS (DVF), which
contained no added CaCl2 and 1 mM EDTA. The pipette solution consisted of (in
mM): 75 CsSO4, 55 CsCl, 10 EGTA, 5 MgSO4 and 10 Hepes.

All recordings

were made at room temperature. Currents were amplified and filtered using an
Axoclamp-200B Amplifier, digitized with a 1322A DigiData digitizer (20 kHz), and
collected using a computer running the Clampex 9.2 software (Axon Instruments,
Inc., Foster City, CA, USA). Data were subsequently analyzed using Clampfit
9.2 (Axon Instruments, Inc.).

Reagents and Statistical Analysis
The following drugs were used in this study: arachidonic acid (AA) , thapsigargin
(TG) (Alamone Labs, Jerusalem, Israel) endomorphin-1 (EM), met-enkephalin
(ME), PGD2 and PGE2 (Cayman Chemical, Ann Arbor, MI), OBAA (Santa Cruz,
Santa Cruz, CA) and fura-2-AM (Molecular Probes, Inc., Eugene, OR). Imaging
data files were converted to text format and imported into SigmaPlot 11 and
Clampfit 9.2 for analysis. Statistical analysis was performed by SigmaPlot 11
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using paired and unpaired t-tests and Two-Way ANOVAs to determine
significance within a group or between groups. The differences between groups
are significant if p<0.05.
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RESULTS

Opioid Receptor Agonists Inhibit SOC Activity
Experiments were carried out to determine the effects of µ-opioid receptor
activation in rat intracardiac neurons. Intracardiac neurons were incubated in 4
µM thapsigarin (TG), an inhibitor of sarco-endoplasmic reticulum calciumATPase (SERCA), to passively deplete the endoplasmic reticulum of calcium and
elicit CCE. Cells were initially bathed in divalent-free PSS, followed by a 2 min
application of normal PSS.
concentration ([Ca2+]I)

The subsequent increase in intracellular calcium

is defined as SOCE or CCE.

Figure 3.1 shows

quantitatively the effects of EM (D) and ME (B) on CCE and representative traces
of [Ca2+]i at each sampling interval (A&C).

Cardiac neurons were pre-

incubated in met-enkephalin (ME), a µ-opioid specific agonist, for a minute and
applied during the reintroduction of a 2.5 mM calcium solution (Figure 3.1 A-B).
ME depressed SOC activity considerably, decreasing peak calcium influx from
272 +17 nM to 107 +19 nM. Endomorphin-1 (EM-1) was more potent than metenkephalin, reducing mean Peak ∆[Ca2+]i from 141+6 nM to 6+1 nM even at 1
µM (Figure 3.1 C-D).

Pronounced effects of EM were reversible following a

5min PSS wash (220 +11 nM).

When the two different opioid receptor ligands
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were applied to the neurons their SOC activity was attenuated comparably.
Therefore it is possible that the MOR is coupled to a G-protein, activating an
inhibitory signaling cascade.
A PTX-sensitive G-protein is Recruited Following µ-opioid Receptor
Activation
Stimulation of MOR in intracardiac neurons has been shown to result in
the activation of a PTX-sensitive G-protein. To determine if a PTX-sensitive G
protein couples µ-opioid receptors to SOC, we obtained values for ∆[Ca2+]i using
the add back protocol (as previously described in Figure 3.1) before and after
PTX-treated (200ng/µL) cells were exposed to EM.

By blocking G-protein

activation via PTX, EM-induced depression of SOC activity was reduced,
indicative a reduction of percent block from control levels (Figure 3.2). Percent
block under control conditions was established by evaluating

∆[Ca2+]I following

Ca2+ add back in naïve intracardiac neurons before and after EM application in
the absence of PTX. As shown in Figure 3.1 C-D and Figure 3.2 A, C, and D, EM
elicits about a 52 ± 8% block of normal CCE however in populations pre-treated
with PTX this block was reduced to about 27 ± 9% . This is substantial evidence
that a PTX-sensitive G- protein is an integral component within a MOR-initiated
inhibitory pathway that could include PLA2 initiation downstream.
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The MOR and AA are Part of a Common Signaling Mechanism that Results
in the Loss of SOC Function.
Figure 3.4 includes calcium-imaging experiments that determine if this
pathway could be a regulatory mechanism for the CCE. OBAA is unique in
comparison to other PLA2 inhibitors because it lacks structural resemblance to
AA itself. Traditional PLA2 inhibitors often cause pharmacological effects similar
to AA due to their structural similarity to AA. Therefore cultured intracardiac
neurons were store-depleted as previously described and pre-incubated with 50
µM OBAA for 1 hr and the EM-induced block of CCE was compared to control
groups. As in Figure 3.2, control percent block was determined by measuring
∆[Ca2+]I before and during EM application in the absence of PTX.

The opioid

agonist elicited a 73.96 + 4.44 % block in the absence of the inhibitor however in
the presence of OBAA this block was reduced appreciably to 21 + 3%.

Arachidonic Acid Pathway Inhibits CCE
To further dissect the second messenger system linking MOR to SOC in
intracardiac neurons, we examined the role of PLA2 in this cascade.

It is

important to note that the PTX-sensitive Gi/o has been linked to PLA2 activation
(Faber and Sah 2004). Representative traces of ∆[Ca2+]i and quantitative data in
Figure 3.4 A-B show that application 6 µM AA markedly reduces SOC activity.
AA evokes an 80% block of CCE and this effect was readily reversible upon PSS
wash, tripling peak ∆[Ca2+]i levels during the add back following the low AA level
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exposure (102 + 6 nM to 31+ 5 nM ). Also, AA precursor linoleic acid (LA)
decreased CCE (245 + 15 to 132 + 21). Unlike AA, the effects of LA were not
reversible upon wash-out using PSS (data not shown).

The effect was only

reversible upon application of BSA (Figure 3.4C&D).

Prostaglandins Show No Significant Effect on SOCE
As shown in Figure 3.4, the AA pathway seems to have an appreciable
effect calcium entry following store depletion.

Therefore, it is imperative to

explore whether AA and/or prostaglandins have a direct effect on the SOC
channel.

To test whether SOCs are influenced by prostaglandins, rat

intracardiac neurons were depleted using TG as described before and mean
peak calcium concentration was measured intracellularly following calcium add
back in the absence and presence of PGD2 (Figure 3.5 A-B) and PGE2 (Figure
3.5 C-D).

The results suggest that neither prostanoid has the ability to effect

SOC channel activity.

Opioid Agonists Block the ICRAC
Whole-cell patch clamp electrophysiological experiments were used to
gain further insight into the specific ion channel modulated by MOR.

It is

important to note that certain conditions were followed to ensure that the ICRAC
only, as opposed to another calcium current, was evoked. First, neurons were
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hyperpolarized using voltage steps of -60mV to -100mV, below range for
activation of VGCCs. Second, stores were depleted by bath application of 10
mM caffeine and calcium chelator EGTA (1 mM) in the pipette solution.

A

nominally free calcium solution was able to block the current, indicative of the
ICRAC.
Figure 3.6 shows a time course of the changes in mean peak current in
response to differences in the contents of the applied bath solutions.

First,

electrical access is gained in the 2.5 mM Ca2+ solution, then store depletion and
stimulation of the CRAC current is achieved using caffeine (10 mM) in a NCF for
about 5 min. Then, the currents were evoked using a Na+-rich divalent free
solution. To induce MOR activation, 1 µM EM and 10 µM ME were added to the
bath solution. The mean peak current is greatly diminished from -151 + 15 pA to
-95 + 15 pA (n=6) upon application of EM and -199 + 43 pA to -82 + 16 pA with
ME (n=5) (Figure 3.7). Reintroduction of a DVF solution reverses this response.
These results are similar to the changes in [Ca2+]I seen Figure 3.1.

AA Inhibits the ICRAC in Intracardiac Neurons similar to Opioidergic
Agonists
To determine if AA can mimic the effects of MOR activation, a similar time
course was used as in Figure 3.6 and 3.7. We applied 6 µM AA to the bath to test
proposed SOC inhibition due to activation of an intracellular opioid signaling
cascade.

Similar to results demonstrated in Figures 3.6 and 3.7, mean peak
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currents were diminished from maximum of -116 + 16 pA during the time
course to -40 + 8 pA.

In addition, to eliminate the possibility that arachidonic

acid- regulated calcium currents (ARCs) are being activated during the AA
application, AA was added to the inhibitory NCF solution following AA depression
of the current. AA was unable to potentiate any calcium current in the NCF
solution (Figure 3.9). As previously seen in prior experiments, the NCF solution,
even in the presence of AA, was attenuated (105 + 37 pA to 78 + 12 pA) the
current (Figure 3.8).
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Figure 3.1. MOR agonists depress CCE. A, Representative traces of ∆[Ca2+]i from a
single neuron for before (control, solid) and after a 5 min met-enkephalin (10 µM)
treatment (ME, dotted) for calcium add back. Line above trace represents a 2 min 2.5
mM Ca2+ application. B, Bar graph of mean (± SEM) peak ∆[Ca2+]i for control and
met-enkephalin (ME)- treated groups in response to calcium add-back. Asterisk above
ME bar indicates significant difference from control condition (n=27, P < 0.001). C,
Representative traces of ∆[Ca2+]i evoked using the add-back protocol for control
(solid), 1 µM endomorphin-1 (EM, dotted), and following a 5 min PSS wash of the µopioid receptor agonist (Wash, dashed). Line above trace represents a 2 min 2.5 mM
Ca2+ application. D, Bar graph of mean (± SEM) values of peak ∆[Ca2+]i obtained
using the add-back protocol and the same conditions as (C.) (n=50). Asterisk above
EM bar indicates significant difference from control group (P < 0.001)
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Figure 3.2. A PTX-sensitive G-protein is Recruited Following MOR Activation. A,
Representative traces of ∆[Ca2+]i for a single neuron recorded in the absence
(solid, PSS) and presence (dashed, EM) of 1 µM EM. Line above trace
represents a 2 min 2.5 mM Ca2+ application. B, Representative traces of
∆[Ca2+]i for a single neuron exposed to 200 ng/mL overnight, PTX alone (solid,
PTX), and PTX plus 1 µM endomorphin-1 (dashed, PTX + EM). C. Bar graph of
mean (± SEM) values of peak ∆[Ca2+]i obtained from cells (n=21) in PSS (black,
PSS) in the absence (Control) and presence of endomorphin-1 or following
preincubation (n=23) in PTX (PTX, grey) in the absence (Control) and presence
(EM) of EM. Asterisk above EM in PSS shows significance from the PSS Control
(P<0.05). Pound above PTX in PSS shows significance from PSS (P<0.05).
The two-Way ANOVA method of statisitical analysis was used to determine
significance. D, Bar graph of mean percent inhibition of peak ∆[Ca2+]i observed
when endomorphin-1 was applied alone (PSS, n = 21) or following preincubation
in PTX (PTX+EM, n=23). Asterisk above PTX+EM bar indicates significant
difference from PTX group (P < 0.001).
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Figure 3.3. OBAA Reverses MOR-Induced Inhibition of SOCE. A, Representative
traces of ∆[Ca2+]i for a single neuron recorded in the absence (solid, PSS) and presence
(dashed, EM) of 10 µM EM. Line above trace represents a 2 min 2.5 mM Ca2+
application. B, Representative traces of ∆[Ca2+]i for a single neuron exposed to the
PLA2 inhibitor, 50 µM OBAA (solid, OBAA), and the PLA2 inhibitor plus 10 µM EM
(dashed, OBAA + EM). Cell was exposed to OBAA for 1 hr prior to the experiments
being carried out. C, Bar graph of mean (± SEM) values of peak ∆[Ca2+]i obtained from
cells (n=67) in PSS (black, PSS) in the absence (Control) and presence of EM or
following preincubation (n=41) in OBAA(OBAA, grey) in the absence of EM (Control)
and presence of EM (EM). Asterisks above EM in PSS shows significance from the
PSS Control (P<0.05). Asterisk above and EM in OBAA shows significance from OBAA
in PSS (P<0.05). Pound symbol above EM in OBAA shows significance compared to
EM in PSS (P< 0.05). The two-Way ANOVA method of statistical analysis was used to
determine significance. D, Bar graph of mean percent inhibition of peak ∆[Ca2+]i
observed when EM was applied alone (n=67) or following preincubation in OBAA
(n=41). Asterisk above OBAA bar indicates significant difference from Control group (P
< 0.001).
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Figure 3.4. AA and LA Inhibit CCE. A, Representative traces of ∆[Ca2+]i for a
single neuron using the add back protocol for control (solid, Control), a treatment of
6 µM AA (dashed, AA), and a PSS wash (dotted, Wash) for add back duration.
Line above trace represents 2.5 mM Ca2+ application. B, Bar graph of values
mean (± SEM) Peak ∆[Ca2+]i for control, drug-treated, and wash groups (n=15).
Asterisk above AA and Wash bars indicate significant difference from control group
(p <0.001). C, Representative traces of ∆[Ca2+]I from a single neuron following Ca2+
add back before (solid, Control) and after LA 6 µM (LA) exposure (dotted, LA) and
following 0.05 mg/mL BSA wash out (dashed, Wash). D, Bar graph of values
mean (± SEM) peak ∆[Ca2+]i for control, drug-treated, and wash groups for the
duration of the add back (n=30). Asterisk above LA bar indicates significant
difference from control group.
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Figure 3.5. Prostaglandins Show No Significant Effect on SOCE. A, Representative
traces of ∆[Ca2+]i from a single neuron for before (solid, control), after a 5 min PGD2
(1 µM) treatment (dotted, PGD2), and wash (dashed, Wash). Line above trace
represents a 2 min 2.5 mM Ca2+ application. B, Bar graph of mean (± SEM) peak
∆[Ca2+]i for control and PGD2 treated groups in response to calcium add-back
(n=139). C, Representative traces of ∆[Ca2+]i evoked using the add-back protocol for
control, 1 µM PGE2 (dotted, PGE2,), and following a 5 min PSS wash of the
prostanoid (dashed, Wash). Line above trace represents a 2 min 2.5 mM Ca2+
application. D, Bar graph of mean (± SEM) values of peak ∆[Ca2+]i obtained using the
add-back protocol and the same conditions as (C.) (n=48).
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Figure 3.6. EM blocks the CRAC. Mean Peak currents were measured from
intracardiac neurons (n=6). Electrical access was obtained in a 2.5 mM calciumcontaining bath solution with a holding current of -60 pA. Cells were dialyzed
with a 75 mM CsCl/ 55 mM CsSO4/ 10 mM EDTA patch pipette solution and
stepped from -60 mV to -100 mV. Then a nominally calcium-free (NCF) solution
containing 10 mM caffeine was applied to the bath to assist with the depletion of
intracellular stores for 5 min. Then, the divalent-free solution (DVF) was bath
applied to replace any Ca2+ ions with sodium ions so that Soc activity could then
be measured as function of current carried by Na+ ions. The Na+- ICRAC was
attenuated by bath application of EM-1 (1 µM) in a DVF solution for 2 min
following by a 2 min wash-out. Then a nominally calcium free solution was
applied to ensure the presence of the ICRAC only and no other current was evoked
during the course of the recording.
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Figure 3.7. ME blocks the CRAC current. Mean Peak currents were measured
from intracardiac neurons (n=5). Electrical access was obtained in normal 2.5
mM calcium containing bath solution with a holding current of -60 pA. Cells
were dialyzed with a 75 mM CsCl/ 55 mM CsSO4/ 10 mM EDTA patch pipette
solution and stepped from -60 mV to -100 mV. Then a nominally-free calcium
solution containing 10 mM caffeine to was used assist with the depletion of
intracellular stores for 5 min. Then, the divalent-free solution was bath applied
to replace any Ca2+ ions with sodium ions. The Na+- ICRAC was attenuated by
bath application of ME (10 µM) in a DVF solution for 2 min following by a 2 min
wash-out.
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Figure 3.8. AA Inhibits the ICRAC similar to Opioidergic Agonists. Mean Peak
currents were measured from intracardiac neurons (n=5). Electrical access
was obtained in normal 2.5 mM calcium containing bath solution with a holding
current of -60 pA. Cells were dialyzed with a 75 mM CsCl/ 55 mM CsSO4/ 10
mM EDTA patch pipette solution and stepped from -60 mV to -100 mV. Then a
nominally-free calcium solution containing 10 mM caffeine was used to assist
with the depletion of intracellular stores for 5 min. Then, the divalent-free
solution was bath applied to replace any Ca2+ ions with sodium ions so that Soc
activity could then be measured as function of current carried by Na+ ions. The
Na+- ICRAC was attenuated by bath application of AA (3 µM) in a DVF solution
for 2 min following by a 2 min wash-out.
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Figure 3.9. AA Failed to Activate any Calcium Current. Mean Peak currents
were measured from intracardiac neurons (n=5). Electrical access was obtained
in normal 2.5 mM calcium containing bath solution with a holding current of -60
pA. Cells were dialyzed with a 75 mM CsCl/ 55 mM CsSO4/ 10 mM EDTA patch
pipette solution and stepped from -60 mV to -100 mV. Then a nominally-free
calcium solution containing 10 mM caffeine was used to assist with the depletion
of intracellular stores for 5 min. Then, the divalent-free solution was bath applied
to replace any Ca2+ ions with sodium ions. The Na+- ICRAC was attenuated by
bath application of AA (3 µM) in a DVF solution for 2 min following by a NCF
solution containing AA to ensure that there were no AA-modulated currents
evoked during the electrophysiological recordings involving AA.
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Discussion

The outcome of this study supports the hypothesis that MOR activation
and AA acid inhibit SOC channel activity. Additionally, it is likely that opioid
receptor activation exerts its inhibitory effects through the production of AA via a
PTX-sensitive G-protein. Calcium imaging and electrophysiology confirms the
hypothesis that MOR agonists inhibit SOC function and the ICRAC (Figures 3.1,
3.6 and 3.7).

This finding along with studies that suggest SOC activity regulates

action potential firing indicates that MOR activation may also suppress
intracardiac neuronal function (DeHaven and Cuevas 2004). While it has been
firmly established that opioids exert their cardioinhibitory effects primarily via the
CNS, studies involving intracoronary administration of opioid receptor antagonist
naloxone suggest that opioids may operate more locally to modulate cardiac
function (Caffrey, Gaugl et al. 1985). Results in the current study and the fact
that peripheral opioid concentrations spike in cases of congestive heart failure
and circulatory shock align with the results of the aforementioned study (Barlow,
Deo et al. 2006; Vargish, Reynolds et al. 1980; Schadt and York 1981; Curtis and
Lefer 1982).

76

Studies in rat amygdala pyramidal cells and in rat supraoptic nucleus
neurons suggest that MOR activation changes excitability in these neurons
through a PTX-sensitive G-protein therefore we hypothesize that MOR in
intracardiac neurons may also be G-protein linked (Brown, Johnstone et al.
2000).

In Figure 3.2 SOC activity was restored once the G-protein was

inactivated suggesting that a PTX-sensitive peptide must be activated upstream
of PLA2 induction.
Application of AA inhibitor, OBAA, was used in conjunction with
receptor agonist treatment to ascertain whether PLA2 activation is a result of
MOR activation. A comparison of the percent block exhibited for the PSS control
group and percent block for the groups pre-treated with the inhibitor before and
after opioid application was established to account for any differences in basal
SOC activity endogenous to the two groups. In accordance with the current
findings, AA production following opioid receptor activation has been discovered
in rat amygdala pyramidal neurons.

Their studies also show, following receptor

activation, Gi/o is activated and as a result PLA2 is induced (Faber and Sah
2004).
Furthermore, similar imaging experiments also show that application of
30µM AA abolishes the SOC current induced following store depletion with TG;
its effects were not readily reversible. A normal PSS wash was unsuccessful in
reversing Isoc depression; bovine serum albumin (BSA), which binds free fatty
acids, was mandatory to restore normal channel activity without any direct effects
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on the channel itself (data not shown).

Previous studies have shown similar

inhibition of SOC activity with lower concentration therefore after a 10-fold
decrease in AA concentration, effects were indeed reversible with a PSS wash
(Rychkov, Litjens et al. 2005). Similarly, the ICRAC was blocked following 6 µM AA
application in rat intracardiac neurons.

Successive I-clamp electrophysiology

studies would need to be performed to determine if there is a consequence on
membrane properties of the neuron in the presence of AA. However this finding
is novel because, to date, it has not been displayed in excitable cells.
Membrane phospholipid degradation is altered during myocardial ischemia
shown by the alteration of fatty acid concentrations in vivo. Interestingly, AA and
its precursor LA are both upregulated in cardiac tissue following ischemia and
reperfusion. Therefore in Figure 3.4 A-B the essential dietary fatty acid was used
to determine its effects on the intracardiac neurons that are closely associated
with the myocardium. LA blocked SOCE similar to AA which could suggest a
compounded loss of function of the SOC channel than seen in the presence of
AA alone during ischemic damage.
Studies in guinea pig intracardiac ganglion show that prostaglandins, byproducts of AA, alter the electrical activity of the neurons by attenuating the afterhyperpolarization due in part to a decrease in small –conductance KCa2+ currents
(Jelson, DeMasi et al. 2003). It is also possible that AA and/or prostaglandins
may be acting as a modulator of electrical activity by depression of SOC activity
via direct channel binding. However in the current study, using the rat as the
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model, we show that the identical prostaglandins used in the former investigation,
in fact, do not modulate the SOC channels.
There is evidence of a non-capacitative arachidonic acid-mediated current
(IARC) existing in cell types such as fibroblasts and smooth muscle cells
(Munaron, 1997; Broad, 1999). To ensure that no part of the mean peak current
is due to a contribution of an IARC, we omitted the wash-out and inserted NCF
with 3 µM AA into the conclusion of the time course (Figure 3.9). Inhibition in the
DVF solution by AA was similar (Figure 3.8), most importantly, when AA was
introduced into the bath in a NCF solution there was no increase in the mean
peak current. Therefore we conclude that the total current evoked in the DVF
solution does not contain any AA-modulated current.
It has become evident that opiates exacerbate conditions such as shock
(Holaday 1983; Liang, Imai et al. 1987), heart failure (Liang, Imai et al. 1987),
and myocardial ischemia (Fagbemi, Lepran et al. 1982). However the exact
mechanism by which this phenomenon occurs is unclear. Electrophysiological
studies would be necessary to confirm that modulation of SOC activity via MOR
activation indeed compromises excitability, even though previous studies indicate
that it is probable (Smith and Adams 1999). This study implicates two potent
inhibitors of parasympathetic input to the heart that may be a part of a common
pathway for inhibition of this critical local circuit.
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CHAPTER 4

NEUROCHEMICAL AND GENETIC DETERMINANTS OF EXCITABILITY OF
INTRACARDIAC NEURONS

INTRODUCTION

There are a wide variety neuropeptides within the ganglia that control
communication within the ganglia by modulating neurotransmitter release.
Among these neuropeptides, cardiac met-enkephalin (ME) production is
increased

in

spontaneous

hypertensive

rats

(SHR)

normotensive rats (Dumont, Ouellette et al. 1991).

in

comparison

to

Similarly, the circulating

levels of the peptide, endomorphin (EM), are increased in the ventricles of heart
transplant patients (Ationu, Sorensen et al. 1993).

Given that both of these

peptides activate µ-opioid receptors, the possibility exists that these peptides
may affect cardiac function in diseased hearts.

It is therefore of interest to

determine if µ-opioid receptor (MOR) activation can alter the function of
intracardiac neurons and affect parasympathetic input to the heart.

Pituitary

adenylate cyclase activating peptide (PACAP) which is found within the
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mammalian intracardiac ganglion, promotes neuroexcitability through intracellular
calcium mobilization in neurons from this ganglion (DeHaven and Cuevas 2004).
In contrast, ME elicits elevations in intracellular calcium in intracardiac neurons
by promoting Ca2+ release from intracellular stores (Smith and Adams 1999), but
has been suggested to depress the excitability of these cells (Adams and
Trequattrini 1998).

The study by Adams and Trequattrini, however, focused

primarily on µ-opioid receptor regulation of N-type calcium channels (1998). The
effects on excitability were largely inferred by studies on single action potential
firing (Adams and Trequattrini 1998).
We have determined that there is a store-dependent, inwardly rectifying
current that is carried by Na+ ions in the absence of extracellular calcium in
individual neurons.

This current, ICRAC, is inhibited by the SOC antagonist, Gd3+

at exclusive concentrations as well as arachidonic acid, as shown in Chapter 3.
The PLA2 –dependent free fatty acid has been also responsible for depression of
the ISOC in rat liver cells and HEK293 cells (Rychkov, Litjens et al. 2005; Luo,
Broad et al. 2001).
The central hypothesis of this study is based upon the studies that report
that both µ-opioid receptor agonists and AA are present in the heart at
supranormal levels following a myocardical infarction and could be responsible
for abnormal cardiac function through the alterations in intracellular calcium
concentration (Barlow, Deo et al. 2006; Van der Vusse, Reneman et al. 1997). In
addition to AA and opioidergic agonists having analogous consequences on
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cardiovascular function, there is also the possibility that they are a part of a
common pathway in the intracardiac neuron, as observed in other excitable cell
types such as periaqueductal grey and pyramidal neurons (Vaughan, Ingram et
al. 1997; Faber and Sah 2004).
While this and other studies suggest that both AA and opioid receptor
agonists have deleterious effects on Ca2+ channel conductance and the activity
of excitable cells, the physiological consequences of SOC inhibition, specifically,
by way of AA and µ-opioid activity in excitable cell types are unknown. This is not
surprising considering the lack of conclusive information relating to SOC
expression and function in neuronal cell types.
Studies similar to the current examining modes of SOC modulation in
excitable and non-excitable cell types are beginning to emerge.

The pore-

forming subunit of SOCs, the Orai protein was previously thought to absent in
neuronal cell types. Therefore, to date, there have not been any comparative
assessments

of

Orai

channel

subunit

expression

among

neuronal

subpopulations partly because SOC-dependent modulation of excitability is a
fairly novel concept.

Even though there are a plethora of factors that direct

action potential discharge such as neurochemical influences and synaptic inputs,
understanding ion channel protein expression is mandatory in assembling a
comprehensive analysis of neuronal function.
There are individual morphologies associated with guinea pig intracardiac
neurons: unipolar, mulitpolar, and bipolar termed S, SAH, and P, respectively.
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Each cell type also has disparate electrophysiological profiles. For instance, P
cells display mostly tonic firing whereas S and SAH cell are more associated with
either single or adaptive firing. Relevant to the current study, there are two main
electrophysiological subtypes of rat intracardiac ganglionic neurons, short (I) and
prolonged after-hyperpolarizations (II). Type I neurons are further subdivided
into Ib

and

Im, based on the action potential bursts and multiple firing,

respectively, in response to prolonged membrane depolarizations. Constituting
only 8% of the ganglionic population, Type II neurons fire tonically, similar to Im.
The exact mechanisms by which these neurons manifest these intrinsic firing
patterns independent of factors such as neurotransmitter release have not been
fully described.
This study explores the possibility of Orai-SOC channel expression
influencing endogenous firing patterns in neonatal rat intracardiac neurons.
Orai1 or CRACM1, the pore-forming subunit of the CRAC channel, was
discovered as a result of its central role in the pathology of severe combined
immune deficiency (SCID). T-cells expressing mutated Orai protein sequences
are incapable of Ca2+-dependent activation, rendering the cells incapable of cell
proliferation (Thompson, Mignen et al. 2009).

While the importance of Orai

channel expression and functionality has been explored in immune cells, little is
known about CRAC channel contribution to neuronal function.

The lack of

information is due, in part, to the fact that VGCC have been viewed as the
primary channels involved in Ca2+ entry into excitable cells.
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Orai subunit expression differs among tissue types.

Orai1 and 3 are

found predominately in lymphoid organs, skeletal muscle, hepatocytes, and skin
(Gwack, Srikanth et al. 2008; Mignen, Thompson et al. 2008). Contrastingly,
Orai2 is found mostly in the brain, kidney, lung and spleen (Gross, Wissenbach
et al. 2007; Gwack, Srikanth et al. 2007).
neuronal

subpopulations

homodimerization

and

remains

can

a

However Orai expression among

mystery.

assemble

with

Orai2

Orai1
and

is

capable

Orai3

to

of

form

heteromultimers (Gwack, Srikanth et al. 2007). On the other hand, only Orai1
has been identified as functional in native cells.
Three Orai subunits each have different pharmacologies and biophysical
properties.

Overexpression of Orai1 in HEK 293 cells yields 3-fold higher

current amplitude and displays a more robust Ca2+-dependent inactivation than
Orai2 and 3 expressed in the same cells.

Conversely, fast Ca2+-dependent

inactivation is pronounced in cells overexpressing Orai3 while Orai1 and 2
display more moderate fast Ca2+-dependent inactivation.

Furthermore, the

SOC antagonist 2-aminoethoxyphenyl borate (2-APB) elicits its effects on OraiSOCs through multifaceted mechanisms including modulation of the intracellular
Ca2+ sensor Stim as well as direct influences on Orai subunits. Orai1 and 3 are
potentiated through direct interactions in transfected HEK293 cells whereas
Orai1 and Orai2- ICRAC currents are decreased in cells transfected Stim1.

This

finding implies that the kinetics could vary considerably depending on subunit
expression. Considering the potential alterations channel expression could have
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on cellular function, we must explore the possibility of modified cellular function
with respect to subunit expression (Lis, Peinelt et al. 2007).
First, this study determines the possible contribution of SOCs to excitation
of the neuron; second we used analogous experimental conditions to elucidate
whether AA and opioid agonists alter action potential firing in dissociated
intracardiac neurons. Finally, this study serves as an electrophysiological and
molecular study of the contribution Orai expression has on the innate electrical
activity of intracardiac ganglionic neuronal subtypes.
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METHODS

Cell Culture
All animals used in this study were Sprague-Dawley neonatal rats,
sacrificed using rapid decapitation at 2-5 days old. All procedures were done in
accordance with the regulations of the Institutional Animal Care and Use
Committee.

Preparation and culture of neurons were followed as previously

described (Fieber and Adams 1991). Enzymatically dissociated neurons were
fixed on poly-L-lysine coated coverslips and incubated for 2-5 days in 95% air
and 5% CO2 at 37oC. Following cell culture, isolated neurons were used for
electrophysiological studies.

Whole-Cell Patch Clamp Electrophysiology
Neurons from neonatal rats were enzymatically dissociated and mounted
on poly-l-lysine coated coverslip as previously described. The coverslips were
transferred to the recording chamber of a phase contrast microscope (400X).
Voltages were measured at room temperature in PSS: 140 mM NaCl, 3 mM KCl,
2.5 MgCl2, glucose, 10 mM HEPES, and 2.5mM CaCl2.

Whole-cell perforated

patch clamp technique was utilized as previously described to prevent loss of
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cytoplasmic contents and preserve native physiological responses (Rae, Cooper
et al. 1991; Xu and Adams 1992; Cuevas and Adams 1996).

The pipette filling

solution contained (mM): 75 K2SO4, 55 KCl, 5 MgSO4, 10 Hepes, 198 µg/mL
amphotericin B, and 0.4% DMSO.

The dialyzing method was used for PCR

experiments; therefore amphotericin was omitted from the filling solution and
action potentials were recorded no longer than 5 min following gaining electrical
access (Cuevas, Harper et al. 1997).

Currents were amplified and filtered using

an Axoclamp-200B Amplifier, digitized with a 1322A DigiData digitizer (20 kHZ),
and collected.

Clampex 9 (Axon Instrumrents, Inc., Foster City, CA, USA).

Clampfit, pClamp 9 program was used for analysis.

Reagents and Statistical Analysis
The following drugs were used in this study: arachidonic acid (AA),
(Alamone Labs, Jerusalem, Israel) endomorphin-1 (EM) and Gd3+ (Sigma), Files
were converted to text format and imported into SigmaPlot 11 and Clampfit 9.2
for analysis.

Statistical analysis was performed by SigmaPlot using repeat

measures One-Way ANOVA on Ranks non-parametric analysis, used for multiple
group comparisons.

Cytoplasm Harvest of Individual Neurons
Cytoplasmic contents of individual neurons were isolated using negative
pressure applied to the pipette following electrical recordings.
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Pipettes were

filled with ~ 5 µL of filtered pipette solution. Aspirated cellular contents were
swiftly expelled by gently scraping the pipette tip along the side of the
microcentrifuge tube and carefully applying positive pressure. Individual neurons
that were determined by electrophysiological recordings to be of the same
subpopulation based on firing patterns (single, adapting, and tonic) were included
in the same tube to pool and concentrate genetic material.
included in every

isolation.

5-7 cells were

Due to the small amount of genetic material

expected 1U RNase inhibitor (Promega, Madison, WI) was added to optimize
yield.

Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction
(qRT-PCR)
Gene transcripts were detected using qRT-PCR with Orai1, 2, and 3specific primers (Table 2) (Invitrogen).

Using the RNeasy mini kit (Qiagen,

Mississauga, ON), RNA was isolated, purified, and used in a two-step reverse
transcription and polymerase chain reactions.

The Sensiscript Reverse

Transcriptase Kit (Qiagen, Mississauga, ON) for reverse transcription reactions
of less than 50 ng of RNA was utilized to convert ~45ng of RNA to cDNA. The
oligo-dT priming method, more specific than the random hexamer, was used to
hybridize and prime poly A tails of mRNA for transcription. Per 20 µL reaction, 1
µL Sensiscript reverse transcriptase, 1 µM oligo (dT) primer, 5 µM dNTP,
Sensiscript reaction buffer and 1U RNase inhibitor (Promega, Madison, WI)
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were added to water and allowed to incubate at 37oC for 60 min.

Gene

amplification was achieved using the SYBR® Green JumpStart™ Taq ReadyMix™
(Sigma, St. Louis, MO) and 500 nM primers for each Orai gene. The reaction
was performed in an Applied Biosystems StepOnePlus™ Real-Time PCR
System (Foster City, CA) at 95oC for 15 min, followed by 60 cycles at 95oC for 1
min and 53oC for 30s.

No template controls were included for each gene and

melt curves yielded a single peak, indicating specific amplification. Endogenous
control, GAPDH was included to account for sample-to-sample variations in
reaction performance and errors in sample quantification.
The comparative cycle threshold (Ct) method was employed to determine
relative gene expression. Each reaction was performed in triplicate and mean
cycle threshold values were determined. Mean delta cycle threshold (∆Ct) values
are determined as the difference between the Ct value obtained from the GAPDH
control sample for each neuronal subtype and the Ct value generated from the
genes of interest (Orai1, Orai2, Orai3) for each neuronal subtype:

(∆Ct = Ct (Orai) – Ct (GAPDH))

(Eq. 2)

Significance was determined using the repeat measures One-Way
ANOVA on ranks non-parametric statistical analysis.
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Table 2. Specific primer sets for Orai 1, 2, and 3 (Ohana, Newell et al. 2009)
Orai1
F: GACTGGATCGGCCAGAGTT
R: GAGAGCAGAGCGGAGGTTC
Orai2

F: CCGTGAGCAACATCCACA
R: CAGCCAGGAAAAGCAGGA

Orai3

F: CCACCAGTCACCACACCA
R: CCAGCCCACCAAAACAAC
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RESULTS

Gadolinium

Reduces

Action

Potential

Firing

at

SOC-specific

Concentrations
To determine whether action potential firing is SOC-dependent, we
applied 5 µM Gd3+ to repetitively firing neurons. Figure 4.1 shows representative
traces of action potentials evoked in response to a depolarizing current pulse
(500 ms, +100 pA) before (Control), during (Gd3+) and after wash-out (Wash) of
5 µM Gd3+ . Quantitative data shows a reduction from 7.0 + 0.4 (Control) to 2.6
+ 0.9 action potentials (Gd3+), then back to 4.2 + 1.8 upon wash-out of
gadolinium. The difference from control to drug-treated groups is statistically
different. Action potential discharge was appreciably reduced in the presence of
5 µM Gd3. Upon analysis of the single waveform, there seems to be no effect on
the after-hyperpolarization upon application of Gd3+, however the action potential
amplitude was increased (Figure 4.1C).

Tonic Action Potential Firing is Attenuated upon µ-Opioid Receptor
Activation
We used whole-cell perforated patch clamp electrophysiology in the
current clamp mode to investigate whether opioid agonist, EM-1, has any effect
on action potential firing. Figure 4.2A shows a family of voltage responses
elicited by 500 msec, +100 pA depolarizing current pulses from a single neuron.
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Voltage changes were recorded in the absence (Control), presence (EM-1) and
following wash-out (Wash) of 1 µM EM.

EM blocked action potential firing

appreciably and the inhibitory effects were easily reversible upon wash-out. The
opioid agonist reduced the mean number of action potentials from 3.6 + 0.7
under control conditions to 1.4 + 0.6 in the presence of the drug. Following
wash-out action potential firing was restored to 2.9 + 0.7 demonstrating the
reversibility of the drug (Figure 4.2).

The single action potential waveform

remained unchanged following EM treatment (Figure 4.2C).

Arachidonic Acid Inhibits Repetitive Action Potential Firing in Rat
Intracardiac Neurons
The central hypothesis of this study predicates that µ-opioid receptor
activation leads to AA production and subsequently, SOCE inhibition. To test
whether AA has any influence on tonic firing, we used the whole-cell patch clamp
in the perforated patch clamp configuration in current clamp mode to evoke
action potentials by using depolarizing current pulses (500 ms, +100 pA). In
Figure 4.3, action potential traces recorded before (Control), during (AA) and
following wash-out (Wash) of 3 µM AA are shown.
Prior to AA application, the neurons fired 3.6 + 0.2 mean action potentials.
However following a 5 min application of AA, this mean number decreased
significantly to 1.2 + 0.4 and following a 5 min wash-out of the free fatty acid, the
neurons fired a mean number of 3.0 + 0.8 action potentials over the same
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amount of time. There is an increase in the after-hyperpolarization and decrease
in the amplitude when the single action potential waveforms are transposed upon
one another for analysis.

Action Potential Firing is Dependent upon Orai Subtype Expression
Previous electrophysiological studies suggest that there is a Ca2+ storedependent
neurons.

component to action potential firing in neonatal rat intracardiac
We hypothesize that differences in intrinsic firing patterns may be

attributed to differences in Orai subunit expression.

We used RT-PCR to

determine whether variations in Orai subunit expression contribute to differences
in firing patterns.

Following eletrophysiological data collection, RNA was

extracted and purified from neurons. RNA from neurons displaying similar firing
patterns was reverse transcribed into cDNA. Then, the cDNA template from
each of the experimental groups, single, adapting, and repetitively firing neurons,
was submitted to separtate qRT-PCR reactions. Specific primers (Table 2) were
used to determine the relative levels of mRNA expression of Orai1, 2, and 3.
Contrastingly, Orai3 mRNA expression was relatively low for single and adating
neurons for each isolation (n=3).

For tonically firing neurons, Orai3 mRNA

transcripts were high when compared to the other two neuronal subtypes.
However subunit expression combinations were inconsistent among the
isolations (n=3). We can conclude that tonically firing neurons are unique in that
they express elevated Orai3 mRNA (Figure 4.4).
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Figure 4.1 Low-dose Gadolinium Blocks Action Potential Firing. Representative
traces of action potential bursts recorded from a single cell in response to 500 ms,
+100 pA current pulses before (Control, black trace), during (Gadolinium, red trace)
and following washout (Wash, blue trace) of 5 µM gadolinium (A). Bar graph of the
mean number of action potentials + SEM recorded from 5 neurons under identical
conditions as in A (B). Asterisk denotes significant difference from control group
(p<0.05).) Single action potential wave forms before (Control, black trace), during
(Gadolinium, red trace) and following washout (Wash, blue trace) of gadolinium (C).
Electrical access was achieved using the perforated patch configuration of the whole
cell technique.
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Figure 4.2 Tonic Action Potential Firing is attenuated Upon MOR Activation
Representative traces of action potential bursts recorded from a single cell
in response to 500 ms, +100 pA current pulses before (Control, black
trace), during (EM), red trace) and following washout (Wash, blue trace) of
1 µM endomorphin-1 (A). Bar graph of the mean number of action
potentials +SEM recorded from 5 neurons under identical conditions as in
A (B). Asterisk denotes significant difference from control group (p<0.05).
Single action potential wave forms before (Control, black trace), during
(EM, red trace) and following washout (Wash, blue trace) of EM(C).
Electrical access was achieved using the perforated patch configuration of
the whole cell technique.
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Figure 4.3 AA Inhibits Repetitive Action Potential Firing. Representative
traces of action potential bursts recorded from a single cell in response to
500 ms, +100 pA current pulses before (Control, black trace), during (AA,
red trace) and following washout (Wash, blue trace) of 3 µM arachidonic
acid (A) . Bar graph of the mean number of action potentials + SEM
recorded from 5 neurons under identical conditions as in A (B). Asterisks
denotes significant difference from control group (p<0.05). Single action
potential wave forms before (Control, black trace), during (AA, red trace)
and following washout (Wash, blue trace) of the fatty acid (C). Electrical
access was achieved using the perforated patch configuration of the whole
cell technique.
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Figure 4.4 Comparative qRT-PCR Results Orai 1, 2, and 3 mRNA expression
for Single, Adapting, and Multiple Firing Neurons. Mean ∆Ct values were
determined from ∆Ct values from 3 separate RNA extractions for each neuronal
subtype. Asterisk denotes significant difference of Orai3 subtype mRNA
expression from the multiple firing group in comparison to the other neuronal
subtypes (p<0.05).
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Discussion

The main discovery of this study is, first, that store-operated calcium
channels contribute to repetitive action potential firing. Second, AA and EM both
decrease the number of action potentials fired per unit time in cardiac neurons.
These findings suggest that the reduction of SOC activity via the activation of a
µ-opioid receptor-mediated pathway has the ability to affect the electrical
properties of the neuron.

This study is novel because most of the previous

studies of SOCs and their consequences on cellular physiology are in nonexcitable cell types.

Now we can begin to fully understand the functional

significance and mechanism of action of SOCs in the modulation of action
potential firing not only in intracardiac neurons but all excitable cell types.
The most accepted antagonist for SOCE, Gd3+ at low micromolar
concentrations, was able to reduce action potential firing which suggests that
SOC channels have at least some contribution to action potential firing. We may
exclude the possibility of the VGCC blockade because of their decreased
sensitivity to Gd3+.

Our lab has shown that Gd3+ at low micromolar

concentrations (1 -10 µM) is able to reduce capacitative calcium entry in a dose
dependent manner (unpublished data). Also, it has been shown to block action
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potential firing in baroreceptor neurons at millimolar concentrations through the
inhibition of stretch-activated ion channels (Hajduczok, Chapleau et al. 1994).
Future studies of the effects on possible SOC-dependent action potential firing
may include other direct SOC antagonists such as 2-APB and SKF-96365
because these antagonists have been proven to be responsible for the inhibition
of CCE.

Store-dependent calcium entry is due to the interaction of an

endoplasmic reticulum associated protein, Stim, to the Orai subunit. Therefore
Stim1 antagonist ML-9 may be used in current-clamp experiments as an indirect
method of testing SOC effects on action potential firing.
Interestingly Cd2+-induced blockade of voltage dependent Ca2+ channels
reduced the after-hyperpolarization peak but not the duration of the AHP of the
action potential; which suggests that there may be an unidentified calcium source
in neonatal rat intracardiac neurons (Franciolini, Hogg et al. 2001). It is our
hypothesis that SOCs are likely to be the calcium source that is responsible for
the maintenance of repetitive firing in mammalian intrinsic cardiac neurons.
There is evidence that intracellular calcium oscillations, that is, movement across
that endoplasmic reticulum and plasma membranes by SOCs, particularly, lead
to long-term repetitive action potential firing (Kusters, Dernison et al. 2005).
These results are analogous to those seen as a result of EM-induced µopioid receptor activation in the supraoptic nucleus (SON), nucleus tractus
solitarius (NTS) and dorsal motor nucleus of the vagus (DMV) (Doi, Brown et al.
2001; Glatzer, Derbenev et al. 2007).

It is important to note, relevant to the
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current study, that the intracadiac ganglia receives input from the CNS from the
DMV therefore it would be likely that EM would play an analogous inhibitory role
in the cardiac ganglia.
In addition to Gd3+, the consequences of EM and AA on repetitive firing
are examined in this study as a part of the central hypothesis which claims that
EM-induced attenuation of intrinsic cardiac neuronal activity is a result of the
direct action of AA. To test the validity of this theory, EM and AA were applied at
concentrations that were shown to block SOCE in imaging experiments, 1µM and
6µM, respectively.

Both blocked repetitive firing appreciably, which supports

the original hypothesis.
Using qRT-PCR we found that Orai2 was expressed most frequently
across multiple RNA isolations, consistently in single and adapting neuronal
subtypes, which concurs with previous studies that report Orai2 as being the
most abundant in murine brain cells (Gwack, Srikanth et al. 2007). However, a
separate study purports mRNA Orai3 only as commonly expressed in human
brain cells (Gwack, Srikanth et al. 2007).

Orai3 was expressed at high levels in

repetitive firing primary neonatal rat intracardiac neurons in comparison to the
other subtypes. Proper control of calcium cycling is needed to avoid apoptosis
and maintain firing frequency, in the case of excitable cell types. Initiated by
Ca2+in the vicinity (3-4nM) of the pore the calcium channel, Ca2+-dependent
inactivation is a negative feedback mechanism which limits global calcium
overload (Zweifach and Lewis 1995; Frischauf, Muik et al. 2009).
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Fast Ca2+-

dependent inactivation is most pronounced for the Orai3-ICRAC in comparison to
the remaining two subtypes.

Orai1- ICRAC is unique in that it displays slow

reactivation whereas Orai2- ICRAC and Orai3- ICRAC exhibit subsequent slow
inactivation (Lis, Peinelt et al. 2007). Therefore SOC- dependent action potential
firing may be dependent on its inactivation. Using a quantitative model, Kusters
et al. demonstrates a SOC-dependent model in the maintenance of intracellular
calcium cycling and action potential firing (2005).

Furthermore, it has been

proposed that fast inactivation of SOCs serves to diminish the role of fast Ca2+activated K+ currents in the Ca2+ oscillation mechanism by reducing the voltage
gated calcium component of calcium entry during the after-hyperpolarization
(Zweifach and Lewis 1995).
V-clamp experiments would need to be performed to definitively assess
the contribution of various SOC inactivations on excitability in these primary
cultured neurons. As most of the previous studies involve expression systems,
the results may vary greatly. Intracellular calcium sensor, Stim interacts with Orai
subunits to activate SOCs and exists in two different species, Stim1 and 2. The
current study does not take into account differences in Stim expression.
Therefore when interpreting the results presented here, one must keep in mind
that Stim1 alone or in combination with Stim2 could also be playing a role in
SOC-dependent action potential firing. The limitations associated with this study
may help explain inconsistent molecular data within the experimental groups.
However it maintains its significance in that it exists as the first of its kind to
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determine the potential effect of protein expression, namely a non-voltage
activated calcium channel, on action potential discharge within parasympathetic
subtypes (Won, Whang et al. 2006).
The neurohumoral component plays a central role in the regulation of the
activity of these ganglia and these neuropeptides function in altering the
membrane properties of individual neurons through their differential influences on
Ca2+ channels (Adams and Trequattrini 1998; DeHaven and Cuevas 2004). Each
Orai subunit has distinct biophysical properties; therefore we hypothesize that
differences in expression may contribute uniquely to the action potential
waveform, namely the AHP via large conductance calcium-activated potassium
channel (BKCa2+), and ultimately firing frequency.
Serving as the final common circuit for the processing of parasympathetic
input, the mammalian intracardiac ganglia exists as a very intricate network of
postganglionic

neurons

within

the

cardiac

nerve

plexus.

There

are

intraganglionic as well as interganglionic connections that orchestrate this
integration as well as providing a local means for regulation of the end organ. In
disease states such as congestive heart failure, proper integration of this
information becomes disrupted, having deleterious effects on cardiac function.
The likelihood of this study having overwhelming implications in the pathology of
heart failure is small considering the complex architecture and neurochemistry
associated with these ganglia that may also be influencing firing frequencies.
However these findings could provide information towards the subsequent
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exploration of Orai channels of the cardiac plexus and their regulatory
mechanisms as potential therapeutic targets for heart failure.
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CHAPTER 5

SUMMARY

The data presented here serve as a comprehensive study of the
contribution store-operated calcium channels (SOCs) have to neuronal activity
along with the consequences of opioidergic regulation of SOC channels. While
an excitatory pathway involving SOC activity has been described in the
modulation of intracardiac neurons (DeHaven and Cuevas 2004), this study
offers an inhibitory mode of regulation for SOC channels mediated by µ-opioid
receptor (MOR) activation. Furthermore, a comparative study was conducted to
determine the link between Orai expression and action potential discharge. We
concluded that repetitive firing may be dependent upon Orai3 expression within
intracardiac neuronal subpopulations.
The current study is motivated by previous work elucidating the effects of
various ganglionic neuropeptides on cellular function. Cuevas and Adams found
that VIP potentiates ACh-evoked currents in rat intracardiac neurons via
activation of a PTX-sensitive G-protein (1996). Contrary to previous studies that
claim cAMP is produced following Gs recruitment in neural and ephithelial cells,
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the study was also able to determine that diffusible second messenger cAMP
was not activated following vasointestinal polypeptide (VIP) receptor activation
in rat neonatal parasympathetic neurons. In order to study single channel
conductance, the study utilized excised membrane patch experiments. Outsideout membrane patches involve the detachment of small sections of the
membrane with the outside of the membrane facing away from the electrode to
allow the evaluation of single channel properties.

This electrophysiological

method revealed that VIP augments the ACh receptor channel open probability.
This phenomenon is thought to be responsible for the effects of VIP on cardiac
function (Cuevas and Adams 1996).

Modulating nicotinic cholinergic receptors

(nAChRs), VIP and pituitary adenylate cyclase-activating peptide (PACAP)
initiate pathways that have a common G-protein (Go) in common.

Using

PACAP6-38, a PAC1 and VPAC2 antagonist, this group also found that VIP
elicits its synergistic effects via its binding to the VPAC1 receptor (Liu, Cuevas et
al. 2000).

Contrastingly, exogenous VIP enhances muscarinic synaptic

transmission and excitatory responses within superior cervical ganglia
(Kawatani, Rutigliano et al. 1985).
One study in particular done by our lab, explores the effects of cardiac
peptides VIP and PACAP on neuronal function and the mechanisms by which
they exert their effects.

The study concluded that PACAP and VIP promoted

action potential firing via a mechanism dependent on the mobilization of calcium
from intracellular stores.

Using fura-2 calcium imaging, a biphasic response
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could be observed, intracellular store release followed by an influx into the
cellular cytosol.

The latter phenomenon was suggestive of store-operated

calcium entry.
In a recent study, muscarinic and nicotinic cholinergic receptors have
differential effects on calcium mobilization.

The Adams group shows

pharmacologically that the nACh elicits an ionotropic response involving calcium
influx and subsequent calcium-induced calcium release (CICR) from ryanodinesensitive stores. On the other hand, mACh induces a metabotropic response
that

initiates

phospholipase

C

(PLC),

leading

to

the

activation

of

phosphatidylinositol 4,5-bisphosphate (PIP2), and production of IP3 and DAG.
The intracellular second messenger responsible Ca2+ mobilization from the ER,
IP3 binds to the IP3 receptor channel. At this point, Ca2+, now cytoplasmic as
opposed to membrane bound, rapidly activates Ca2+-dependent K+ channels
before being buffered by the mitochondria or actively resubmitted into the ER via
Ca2+-ATPase pump (Beker, Weber et al. 2003).

Similiary, µ-opioid receptor

agonists have been implicated in the production of inositol trisphosphate (IP3) to
have similar effects on calcium mobilization in rat intracardiac neurons (Smith
and Adams, 1999).
Previous studies confirm that of the five muscarinic receptor subtypes,
mRNA transcripts for M1-M4 are present in rat and guinea pig (Hassall, Stanford
et al. 1993; Hoover, Baisden et al. 1994). Interestingly, chiefly parasympathetic,
the intracardiac neuron is capable of coexpressing more subtypes of the
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muscarinic

receptor

than

any

other

native

cell

type.

Furthermore,

electrophysiological studies confirm that M4 receptor activation, specifically,
modulates voltage-gated calcium channel activity via a PTX-sensitive G-protein
(Cuevas and Adams 1997).

Analogous to outcomes reported here, studies

previous to the latter suggest that muscarinic receptor modulation occurs
through mechanisms that exclude prokein kinase C (PKC), diacylglcerol (DAG),
and adenylate cyclase (AC) (Xu and Adams 1993). Also, the M1 receptor has
been implicated in the inhibition of Im in a variety of autonomic neuronal types
(Bernheim, Mathie et al. 1992; Cuevas and Adams 1997; Xi-Moy and Dun
1995). Whereas K+ channel activity is suppressed following M2 receptor
activation in rat intracardiac neurons through G-protein coupled mechanisms
which concurs with signaling cascades that result in the inhibition of the SOC
(Allen and Burnstock 1990; Xi-Moy, Randall et al. 1993).
Vasointestinal pituitary adenylate cyclase (VPAC1) and pituitary adenylate
cyclase (PAC2) receptor activation has been shown to modulate intracellular
kinases such as protein kinase A (PKA) and protein kinase C (PKC),
respectively, in certain cell types. In addition, NetPhosK 1.0 predicted PKA and
PKC binding sites on the Orai1 subunit.

Therefore we hypothesized that these

kinases, along with cAMP, have an influence on CCE. Using calcium imaging,
we measured changes in neuronal [Ca2+]i before and after incubation in 1 µM
phorbol 12, 13 dibutyrate (PDBu)

using

a conventional calcium add back

protocol following passive store depletion by thapsigargin (TG).
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The PKC

activator did not induce any appreciable deviations in ∆[Ca2+]i from the control
group.

Similarly, membrane permeable cAMP analog, 8-Br-cAMP and,

adenylate cyclase (AC) activator, forskolin did not influence SOCE upon Ca2+
add back.

Both cAMP and AC are a part of a common pathway to PKA

activation therefore we have concluded that PKA does not have an effect on
Orai-SOC channels.
Much variability exists in regard to the reported influences of kinases on
capacitative calcium entry (CCE). The differences are largely dependent upon
cell type and the kinase subtype. Mechanistically, the conflicts could be due to
indirect effects on the plasma membrane-bound channel by store-depletion. In
the present study, Ca2+ stores are depleted prior to drug treatment to ensure that
all effects are direct. However, this study is the first to examine kinase-regulated
SOC activity in excitable cell types and subsequent experiments are required to
fully describe the absolute consequences of kinase activity.
met-enkphalin depletes IP3 sensitive stores as well as

Opioid agonist,

blocks N-type voltage-

gated calcium channels (VGCCs) in intracardiac neurons, specifically (Adams
and Trequattrini 1998; Smith and Adams 1999). Therefore, we hypothesized that
MOR agonists may have an effect on CCE.

To test this hypothesis, we

employed the add back protocol as previously described, before and after 10 µM
ME and EM applications (Figure 3.1). As a result, we were able to conclude that
opioiderigic activation potently inhibits CCE in rat intracardiac neurons.
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This finding is paramount considering that enkephalins have been found to
be a component of the neurochemical profile of the intracardiac ganglionic
neurons. However, the methods by which these peptides modulate cellular
function have not been fully described. While the data presented here provides
only a singular component of the composite effects of opioidergic activity within
intracardiac ganglia, this study is based on the novel premise that SOCs are
expressed in neuronal subtypes as opposed to non-excitable cell types and are
functional and capable of modulation by cardiac peptides. There are a plethora
of reports citing opioidergic inhibition of VGCCs (Jessell 1977; Wilding, Womack
et al. 1995; Adams and Trequattrini 1998). However prior to the present study, no
information concerning SOCs and opioidergic signaling has existed.
Following MOR activation, an intracellualar signaling pathway is initiated,
having direct effects on the channel protein subunit.

In NG-108 cells

overexpressing MOR receptors, PTX was able to attenuate EM-induced
depression of VGCCs, indicating

G-protein coupling. To elucidate whether a

PTX-sensitive G-protein is activated as a result of ligand binding, cells were pretreated with PTX before applying EM. PTX was able to prevent EM-induced
SOCE, proving that a Gi/o protein becomes active in response to opioid peptide
interacting with the MOR. Similarly, in amygdala pyramidal neurons, it has been
shown that a PTX-sensitive G-protein linked to the MOR receptor causes the
activation of PLA2 (Faber and Sah 2004).
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We concluded that there may be a possibility that PLA2 may be a second
messenger in the signaling cascade currently under investigation. First we used
the ketone, AACOCF3 to bind and antagonize PLA2 prior to MOR recruitment
(data not shown). However, we found that the AA analogue had direct effects on
CCE. Therefore we decided to use OBAA a potent, structurally disparate PLA2
inhibitor that does not exhibit direct effects (Kohler, Friedrich et al. 1991). Both
agents were able to attenuate percent inhibition of SOCE due to MOR activity
(Figure 3.1).

These findings suggest that the PLA2 plays a central role in

eliciting MOR-induced reduction in calcium influx following ER depletion.
PLA2 is the key enzyme responsible for phospholipid membrane cleavage
in the production of AA; it is then probable that AA is a subsequent second
messenger in this particular intracellular pathway. An AA-induced decrease in
mean peak SOC currents has been documented in rat liver cells. Therefore
using calcium imaging, I tested the probability that AA could have similar
consequences on CCE in neonatal rat intracardiac neurons. AA was applied to
cells following passive store-depletion with TG in zero Ca2+. AA attenuated
[Ca2+]I increases upon addition of 2.5 mM Ca2+ to the bath.

During this

investigation, we observed that the two lipids AA and its analogue AACOCF3
had negative consequences on the SOC channel. Therefore LA was presented
to the neurons to elucidate further whether the lipid structure was responsible for
this inhibitory phenomenon. In the same manner, LA was able to block the
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activity of the channel indicative of a lipid-protein interaction, detrimental to
channel function.
Along with neural control, the intracardiac ganglia are capable of control
by immune responses. Secreted by interganglionic mast cells, prostaglandins,
which are AA metabolites, are a class of immune mediators that elicit rapid
modulation of the electrical properties of neighboring neurons (Jelson, DeMasi
et al. 2003). Two prostaglandin isoforms in particular, PGE2 and PGD2, reduced
the after-hyperpolarization duration and amplitude via the attenuation of the
small-conductance K+ channels (SKCa2+). However whether they have direct
effects or indirect effects via Ca2+ has not been determined although
prostaglandins have been previously reported to attenuate Ca2+ channels in
other neuronal preparations (Mo, Ammari et al. 1985; Ikeda 1992; Ito, Murai et
al. 2000).
We explored the possibility that this phenomenon may be due to inhibition
of SOCs using the add back protocol as previously described. In the presence of
both PGE2 and PGD2, there was no difference in ∆[Ca2+]i from control values.
Therefore we concluded that these particular prostaglandin subtypes do not have
an influence on SOCE in rat intracardiac neurons. It is important to note that
differences between the rat and the guinea pig should be considered when
making a comparison between any physiological systems because of the
evolutionary hypoxic Andean environment of the guinea pig (Turek, Ringnalda et
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al. 1980). Therefore one must be cautious when establishing function
correlations between the two animal models.
The initial portion of this study used calcium imaging as a tool to assess
the effects of MOR agonists and second messengers in our proposed inhibitory
pathway on CCE. We have proven that

MOR-specific agonists EM and ME

both depress SOC activity following G-protein recruitment. The G-protein is
responsible for activating PLA2, which subsequently cleaves AA from the plasma
membrane to directly interact with the SOC channel.
Using calcium imaging, we assessed the effects of the MOR-mediated
pathway on SOCE through intracellular calcium elevations following store
depletion. However, in order to make a complete assessment we must consider
the Ca2+ current evoked across the plasma membrane in response to store
depletion, ICRAC.

A relatively small current, the ICRAC is blocked at low nM

calcium concentrations; however it is highly selectively for Ca2+ ions. Some
other biophysical properties of the ICRAC are that it is potentiated when Ca2+ is
completely removed from the bath solution and evoked in response to store
depletion by caffeine and EGTA.

Using the appropriate pipette and bath

solutions to detect the ICRAC, I studied the consequences of our proposed
inhibitory signaling cascade on ICRAC using the V-clamp mode of whole cell patch
clamp electrophysiology.
Enkephalins have been shown to block voltage dependent calcium
currents and ME blocks VGCC in rat neonatal intracardiac neurons, specifically
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(Jessell 1977; Wilding, Womack et al. 1995; Xiao, Spurgeon et al. 1993; Adams
and Trequattrini 1998). First, we determined whether EM had a similar effect on
ICRAC as the voltage-dependent calcium current and CCE. After store-depletion
by 10 mM caffeine, a - 160 pA current was evoked in a divalent free (DVF)
solution. However when 1 µM EM was introduced to the bath, this current was
reduced to about - 95 pA (Figure 3.6).

Similarly, 10 µM ME was able to

depress the ICRAC from -225 pA to -75 pA. In both instances, this effect was
readily reversible upon a DVF physiological saline solution PSS wash (Figure
3.7).

These findings are evidence that MOR activity is responsible for a

common inhibitory thread extending from VGCCs to SOC channels and provide
an explanation for the neurosuppression that occurs following release of these
peptides within the mammalian heart.
Next, we used our proposed model created in accordance with the
imaging results to predict that AA would behave similar to the EM and ME in the
control of SOCs. Additionally, AA has been shown to inhibit ISOC in rat liver cells
(Rychkov, Litjens et al. 2005). To test this hypothesis, we applied our protocol
as previously described in the case of EM and ME in the V-clamp
electrophysiological studies. AA was able to attenuate the ICRAC by two-thirds
upon bath application (Figure 3.8), an outcome which is analogous to the results
obtained from the imaging experiments presented previously.
While AA causes a reduction in this capacitative Ca2+ current, a noncapacitative Ca2+ current has been identified that is modulated by AA, IARC,
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arachidonic acid regulated current. Interestingly, IARC seems to be evolutionarily
related yet functionally distinct from other types of calcium channels
(Shuttleworth 2009). In order to differentiate between the IARC and ICRAC in the
current study, AA in a NCF PSS was added to the bath following AA-induced
inhibition of the ICRAC. There was no subsequent current evoked in NCF solution
therefore we have concluded that the current evoked is purely due to calcium
release (Figure 3.9).

Taken

together,

these

electrophysiological

experiments concur with the results of fura-2 calcium experiments that indicate a
MOR-initiated signaling cascade consisting of the production of intracellular
second messengers, leading to SOC inhibition.

Electrophysiology provides a

more precise method which CCE can be studied because we are able to control
precisely the ionic environment according to the biophysical properties of the
SOC channel.

By studying the changes in mean peak current densities in

response to drug bath application, this method offers a more exact and
conclusive method of studying Orai-SOCs, in particular.
Next we asked: Does this current play a functional role in the regulation of
electrical activity of the neuron? The question under investigation is very unique
considering that no other Ca2+ channel aside from VGCC currents has been
found to be integral in the modulation of the membrane properties of the neuron.
However, results of previous studies have suggested VGCCs are not
responsible for modifications in the after-hyperpolarization (AHP) in rat
intracardiac neurons (Franciolini, Hogg et al. 2001). To explore the possibility of
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the involvement of SOCs, we used the most SOC-specific antagonist, 5 µM
Gd3+, to elucidate its influences on repetitive firing in dissociated neonatal rat
intrinsic cardiac neurons.

Using the I-clamp mode of the perforated patch

configuration of patch clamp electrophysiology, we have shown that multiple
action potential firing is converted to adaptive firing in the presence of 5 µM
Gd3+, which is indicative of SOC-dependent control of action potential discharge
in these neurons.

Experiments similar to these using other SOC antagonists

such as SKF-96365 should be performed to confirm Orai-SOC suppression as
Gd3+ is a promiscuous antagonist of cationic channels. However the current
results definitely justify further investigation of the potential role of SOCs as
regulators of membrane properties of the neuron.
We repeated the same I-clamp experiment with EM to determine whether
EM would block action potential (AP) firing similarly.

EM was effective in

reducing action potential firing appreciably from 3.6 + 0.6 to 1.4 + 0.6. The
results of our calcium imaging and V-clamp electrophysiology experiments with
AA indicate first, that AA suppresses SOCE as well as the ICRAC in intracardiac
neurons.

We therefore predicted that AP firing will be suppressed upon

application of AA. Next, we applied the same protocol to elucidate the effects of
AA on AP discharge and found that AP firing was reduced from tonic to adaptive
firing.
So far, we have established that a MOR-mediated pathway is capable of
eliciting a potent reduction of repetitive firing through the ICRAC.
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However the

molecular composition of these channels has not been identified in this or any
other neuronal subtype.

Furthermore, no prior information exists on the

molecular contribution of the individual channel subunits to cell excitability
because Ca2+ regulation of membrane properties has been attributed to the
activity of VGCCs. This study is novel in that its hypothesis is based on recent
studies that indicate there is an alternative source of Ca2+ in these ganglionic
neurons and this source is calcium release-activated not voltage-dependent.
Using I-clamp electrophysiology and RT-PCR, we found that Orai3 was
present in comparably high levels in multiple firing neurons (Figure 4.4). The
fact the Orai3 is associated with robust Ca2+- dependent fast inactivation,
exclusively, suggests that repetitively firing neurons display more robust fastinactivation of SOCE than single and adaptive firing neurons (Lis, Peinelt et al.
2007).
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CONCLUSIONS

In several cardiac disease states, such as congestive heart failure (CHF)
and post-myocardial infarction arrhythmias, decreased parasympathetic and
increased sympathetic tones are observed resulting in sudden cardiac death.
The final common pathway for autonomic regulation of the heart, the mammalian
intracardiac ganglia serve as a major integration center for all parasympathetic
inputs into the heart and are capable of local control over the heart independently
of the CNS. However studies in the canine model indicate that this local control is
compromised in the case of CHF.

Contemporary studies indicate that the

intracardiac ganglia function within the cardiac plexus as a key player in a series
of nested feedback loops rather than linearly.

The loss of parasympathetic

control in the case of heart failure, particularly, is at the level of the intracardiac
ganglia.
Due to the complex architecture of the cardiac nervous system,
intracardiac neurons are able to play both a causative as well as an effector role
in progression and development of cardiac dysfunction.

For instance, cardiac

neurons promote coronary vasodilation and dysregulation of coronary blood flow
in disease states. Furthermore, changes in intracardiac neuronal function are
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observed following myocardial ischemia.

Considering the integral role the

parasympathetic autonomic nervous system plays in the maintenance of proper
cardiac function, the amount of information that exists within the current literature
pertaining to its exact mechanisms of regulation are deficient.

It is through

these studies that we are able to devise pharmacological agents to safely and
effectively treat certain cardiac diseases.
The most commonly prescribed pharmacological therapy for CHF in
particular, digoxin, elicits its negative chronotropic effects by facilitating
parasympathetic tone to the heart (Khand, Rankin et al. 2003; Gheorghiade,
Adams et al. 2004).

Extreme caution must be practiced when prescribing

digitalis because of the narrow therapeutic window associated with digitalis.
Consequently, the development of alternative therapeutic agents is necessary to
facilitate safe and effective management of critical cardiac disease states.
The complexity of the neurocircuitry as well as the neurochemistry of
these ganglia demands comprehensive studies of its modes of regulation in the
complete assessment of its contribution to cardiac function. Along with changes
in neural transmission, there are also changes in the neurohumoral component of
the intrinsic cardiac ganglia associated with an array of cardiac conditions.
Relevant to the current study, cardiac opioid and enkephalin production is
transformed in an array of diseases such as cardiomyopathy, heart failure, and
genetic hypertension resulting in disease progression. Additionally, in the dog,
the severity and incidence of cardiac arrhythmias were attenuated following

123

opioid receptor antagonism. The mechanisms by which these peptides exert their
effects are poorly understood. The conclusions attained in the current endeavor
align with those that claim MOR stimulation is responsible for the inhibition of
VGCCs in parasympathetic neurons of the nucleus ambiguus and the superior
cervical ganglionic neurons.

Therefore, this study may provide additional

insight into a possible method by which these peptides cause detrimental
alterations to cardiac physiology.
Experiments executed here are paramount in that they contribute to the
understanding of a voltage-independent source of calcium to excitable cells,
because SOC channels were previously thought to be restricted to non-excitable
cell types. We prove that Orai-SOC channels, particularly, are not only expressed
but they are indeed functional in a neuronal cell and contribute appreciably to
cellular

excitability.

The

comparative

evaluation

of

molecular

and

electrophysiological properties serves as the first to establish a link between Orai
expression and membrane properties within neuronal subtypes. Furthermore, our
observations in intracardiac neurons could pioneer similar research on storeoperated methods of calcium regulation in other neuronal types. Future studies
would reveal additional modes of modulation for these channels and could lead
to unique, new pharmacological interventions as that target the regulation of
intracellular calcium concentrations.
Our proposed pathway indicates AA as the singular and direct second
messenger leading to SOC antagonism.
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Considering the fact that AA is

upregulated following ischemia and reperfusion in vitro, the phospholipid could
lead to disruption of normal autonomic function independent of MOR activity
therefore the implications for potential therapies are compounded in this respect.
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APPENDIX 1:
LIST OF ABBREVIATIONS

2-APB - aminoethoxydiphenyl borate
OBAA - 4-4- Octadecylalkybenzoylacrylic acid
ACh - acetylcholine
AC - adenylate cyclase
AHP - after-hyperpolarization
AA - arachidonic acid
AV - atrioventricular
BSA - bovine serum albumin
KCa2+ - calcium-dependent potassium channels
ICRAC - calcium release-activated current
CICR - calcium-induced calcium release
CaM - calmodulin
CCE - capacitative calcium entry
ChAT - choline acetyl transferase
CHF - congestive heart failure
cAMP - cyclic adenosine monophosphate
DAG - diacylglcerol
DMSO - dimethyl sulfoxide
DVF - divalent-free
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DMN - dorsal motor nucleus
P - efferent postganglionic neurons
EM - endomorphin
HF - heart failure
HVA - high voltage –activated
IP3 - inositol trisphosphate
IN - interneurons
[Ca2+]i - intracellular calcium concentrations
BKCa2+ - large conductance calcium-activated potassium channel
LA - linoleic acid
ME - met-enkephalin
MLCK - myosin light-chain kinase
mAChRs – muscarinic cholinergic receptors
nAChRs - nicotinic cholinergic receptors
nAChRs - nominally calcium free (NCF)
NA - nucleus ambiguus
NCF-nominally calcium-free
NTS - nucleus tractus solitarius
PDBu - phorbol 12, 13 dibutyrate
PIP2 - phosphatidylinositol 4,5-bisphosphate
PLA2 - phospholipase A2
PLC - phospholipase C
PSS - physiological saline solution
PAC - pituitary adenylate cyclase
PACAP - pituitary adenylate cyclase-activating peptide
PGD2 - prostaglandin D2
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PGE2 -prostaglandin E2
PKA - protein kinase A
PKC - protein kinase C
ROS - reactive oxygen species
ROCCs - receptor-operated calcium channels
SCID - severe combined immune deficiency
SA - sinoatrial
SIF - small, intensely fluorescent cells
SKCa2+ - small-conductance calcium channels
SOCs - store-operated calcium channels
SOCE - store-operated calcium entry
SON - supraoptic nucleus
TG - thapsigargin
VIP - vasoactive intestinal polypeptide
VPAC - vasointestinal pituitary adenylate cyclase receptor
VGCCs - voltage-gated calcium channels
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